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Abstract
This study focuses on how healthcare data can be used to draw comparisons between healthcare providers
(surgeons or hospitals). Depending on the type of access to datasets, these comparisons can be done
with or without risk adjustment. For us, risk adjustment refers to the use of patient-level information
to explain variation in healthcare spending, resource utilisation and health outcomes.
For unadjusted comparisons, we highlight the diagnostic potential that radar plots offer for reporting
on outcome indicators. These outcome indicators were obtained from hospital admissions of patients
undergoing certain surgical procedures. We address two drawbacks of radar plots: presence of missing
information and order of indicators. By introducing a consolidated view at provider level, we define an
uncomplicated ranking of providers which can be used to identify potential low and high performers.
For risk adjusted comparisons, we introduce a novel and robust methodology that enables comparisons
of healthcare providers across multiple hierarchies, namely, surgeons, teams, departments and hospitals,
using a consistent approach. Our methodology puts the patient at the centre of the analysis, and thus,
can be used for personalised predictions (e.g. expected length of stay, costs and probability of being
transferred to intensive care unit).
Our findings suggest that the observed variation in selected outcome indicators, such as length of stay
and charges of healthcare providers, cannot be explained by patient characteristics alone. Importantly,
we have also observed that the perceived performance, on selected outcome indicators, of providers can
change substantially following risk adjustment.
Healthcare is unique in that clinical expertise is essential in guiding decision making and in informing
all statistical models that seek to describe patient outcomes. For future iterations of our models, we will
seek greater clinical input.
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Introduction
Experts from different research environments and policy makers alike [1, 2, 3] agree on two important
aspects of the current Australian healthcare system that urgently need improvement:
i) data collection; and
ii) performance information sharing.
There exists an acute level of data fragmentation which creates an environment in which patients,
their next of kin and their service providers go through the system while knowing little or nothing at all
of their journey [2].
The healthcare system is littered with data, but performance and quality information is poorly
collated, not shared with patients and often not given to the doctors and hospital managers responsible
for keeping patients safe [4].
Despite this, several Australian institutions provide highly technical guidelines that can be used for
comparing performance of healthcare providers, such as hospitals or surgeons, on specific indicators healthcare
provider[4, 5]. There are other methodologies from overseas that can, in principle, be tailored to the Australian
context. As an example, we can find detailed explanations and a step-by-step guide of an American
model [6, 7].
However, none of these methodologies tackles a fundamental issue. Consider the following scenario,
given a risk adjustment methodology used for predictive purposes, like the American model, we expect
that two similar patients will bear similar costs. But, what does “similarity” mean between patients? Is
there a way to quantify it?
The American risk adjustment model provides a risk score per patient. We could argue that this
risk score could be a measure of similarity. In fact, by following the American methodology, any risk
adjustment model based on a regression model could provide a risk score for each patient. Nonetheless,
a group of patients having similar risk scores could be made up of men and women of all ages with a
different combination of comorbidities, if at all present.
Categorical based risk adjustment models [8] and clustering techniques [9], have a specific way to
define similarity between patients: similar patients are those who belong to the same category or cluster.
However, by splitting all our patients in specific categories and without a way to measure similarity
between them, we do not know if a patient is being compared against patients with a large degree of
dissimilarity.
Another important aspect that needs better understanding is healthcare variation. Some variation is
expected and associated with factors such as underlying differences in the health of specific populations
or personal preferences. Some studies show that the variation exhibited in different areas is unwarranted
[1, 10] while other studies do not consider patient characteristics as part of their analysis [11].
Our research started by considering the performance of healthcare providers using indicators in ad-
ministrative data. We used radar plots to visualise the variation presented in our selected indicators.
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At this initial stage, no risk adjustment was considered to account for individual health status. Conse-
quently, the only meaningful comparisons were made between healthcare providers with similar casemix
of surgeries performed.
In order to factor-in the the complexity of a patient’s health, we used hospital administrative datasets
supplied by an Australian private health insurer. We defined a health profile to be the encoding of ahealth profile
patient’s health status.
With our health profile defined, we introduced our concept of “similarity” between patients. Hence,
we started comparing patients against similar patients only. This is a novel approach that aims at having
the patient at the centre of the analysis.
We were able to provide risk adjusted benchmarks for each patient and for each of their selected
outcome indicators. These benchmarks, at patient level, can potentially be used for predictive purposes.
Hence, we aggregated our patient level comparisons at surgeon and hospital levels. In fact, our
research allowed us to compare each healthcare provider against a personalised cohort of patients that
exhibited similar health profiles as those treated by the provider. Thanks to this we could analyse
the relative frequency of outlying behaviour that healthcare providers had and define risk adjusted
benchmarks for each provider as well.
In summary, our contributions are the following:
i) the creation of a health profile for every patient;
ii) analysis of the relative frequency of outlying behaviour of healthcare providers. This outlying
behaviour is obtained by using the health profile of similar patients;
iii) risk adjusted benchmarks at patient and medical provider levels;
iv) a comprehensive methodology to carry out steps i to iii.
With this work, we were able to establish risk adjusted and unadjusted comparisons of healthcare
providers. Furthermore, after taking into account different outcome indicators and patient characteristics,
we can point out healthcare providers which should be investigated further to understand other possible
factors, not included in our model, which may be responsible for large variations in their costs and
outcomes.
The structure of the thesis is as follows.
Chapter 1 presents background information that is important in order to understand the Australian
healthcare system. Furthermore, it provides the context around the International Classification of Dis-
eases 10th revision (ICD10) codes, that are included in administrative data and used in our analysis.ICD10
Since our focus is to create a patient health profile using ICD10 codes, we describe three clinical clas-
sifications of ICD10 codes: Charlson conditions, Elixhauser conditions and HHS-HCC conditions. The
HHS-HCC stands for the United States’ (US) Department of Health and Human Services - Hierarchi-HHS-HCC
US cal Clinical Conditions diagnostic classification system. Current methodologies developed in Australia
and overseas that aim at comparing healthcare providers are also discussed, including a couple of poten-
tially useful methodologies, namely matching methods and clustering techniques. We explain why we
moved away from these two methodologies. Our methodology for comparing healthcare providers can
be considered as an outlier detection algorithm; therefore we provide a brief summary of this type of
algorithms.
Chapter 2 provides detail descriptions, graphs and tables of the datasets supplied by our industry
partner, a large private health insurer in Australia.
Chapter 3 contains our initial unadjusted comparison of providers. These comparisons are made
through radar plots which we designed and called scorecards. Our scorecards provide a clear way toscorecards
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compare the outcome of a patient admission. We can aggregate our scorecards at different levels: surgeon
level, hospital level and national level. In a simple way, we use them to find out which hospitals may be
low and high performers. Pros and cons of our scorecards are also discussed.
Chapter 4 presents our risk adjustment methodology. This chapter starts by comparing several
exhaustive clinical classifications of ICD10 codes. We justify our choice of a shorter version of the HHS-
HCC over Charlson, Elixhauser or the full HHS-HCC conditions for creating our patient health profile.
Afterwards, we explain in great detail how we find patients with “similar” health profiles and our concept
of neighbourhood of a patient. In short, the neighbourhood of a patient p is the set formed by patients neighbourhood
“similar” to p. This chapter presents also the different comparison mechanisms that we used, including
the definition of our personalised benchmarks.
Chapter 5 explains how our risk adjustment methodology can be used for predictive purposes. It also
introduces visualisations developed for risk adjusted comparisons of providers.
Finally, this thesis is concluded with a quick overview of our contributions and several open questions
that will continue to motivate our future research.
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Chapter 1
Australian healthcare data and
analysis methods
Despite the challenges of data fragmentation and performance information sharing in the current Aus-
tralian healthcare system, researchers have been exploring ways to measure performance in current
datasets, compare healthcare providers and summarise this information for providers to assess.
This chapter presents main definitions, background information and current research done. We start
by providing a succinct overview of the Australian healthcare system.
We also explain in great detail a type of dataset we had access to: hospital administrative dataset. An
administrative dataset [12] is the term given to those data collections that are made up of information administrative
datasetthat is routinely collected during the delivery of a service. Of interest to us is the Hospital Casemix
Protocol HCP inpatient dataset. The HCP inpatient dataset is a valuable source of information for HCP
the private health industry. It is collected and used for policy, management, monitoring, evaluation
and research purposes. The HCP inpatient dataset stores up to 50 diagnosis conditions among other
information. These diagnosis conditions are coded using the International Classification of Diseases, 10th
revision, Australian modification (ICD10-AM) [13]. Thus, in this chapter, we also give an overview of ICD10-AM
the ICD10 codes [14].
We want to develop a patient health profile that benefits from the diagnosis conditions stored in the
HCP inpatient dataset. Nonetheless, there are more than 10,000 ICD10-AM codes [15]. In order for
us to be able to work with all of them, we require an exhaustive clinical classification of ICD10-AM
codes. Therefore, we studied three clinical classifications namely, Charlson, Elixhauser and HHS-HCC.
Recall that HHS-HCC stands for the United States’ (US) Department of Health and Human Services -
Hierarchical Clinical Conditions (HHS-HCC) diagnostic classification system [6].
Towards the end of this chapter, we present current methodologies used for comparing healthcare
providers and risk adjustment. We also present two popular techniques that could have been used for
making meaningful comparisons among healthcare providers and our reasons for not using either of them.
One of our main contributions in this work is the development of our risk adjustment methodology which
can be considered as an outlier detection algorithm. For this reason, we also include a brief summary of
this type of algorithms.
1.1 Australian healthcare system: an overview
The material presented in this section was mostly extracted from “The Australian Health Care System”
[16] and references therein unless otherwise specified.
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1.1.1 Medicare
Medicare is Australia’s universal health insurance system. The principal objective of Medicare is toMedicare
remove or reduce financial barriers to access healthcare for all Australian residents. In fact, Medicare
covers free treatment for public patients in public hospitals and subsidised private treatment, including
visits to General Practitioners (GPs). The Australian Government subsidises private treatment throughGP
the payment of rebates or benefits for medical services listed in the Medicare Benefits Schedule (MBS)MBS
[17].
The MBS sets out the MBS fee and the Medicare rebates for approximately 5,700 services. The MBS
coverage for medical services and the MBS fee, which is the amount of money that the MBS pays forMBS fee
each service, are usually reviewed annually by the Department of Health and Ageing in consultation with
the medical profession, taking into account the time involved in performing a service and its complexity.
In most cases, MBS fees are indexed every year on 1 November [17].
Doctors can fully settle their bill by accepting the government payment (rebate) directly from Medi-
care, a process known as bulk billing. Alternatively, doctors can bill their patients and there is nobulk billing
limit on what fees may be charged. Patients then obtain a rebate from Medicare for a percentage of the
government MBS fee, and the remaining gap between the doctor charge and the rebate is paid by the
patient.
Regarding the absence of a ceiling price on medical bills, we refer to Section 51 (xxiiiA) of the
Constitution of the Commonwealth of Australia [18]:
“The Parliament shall, subject to this Constitution, have power to make laws for the peace, order,
and good government of the Commonwealth with respect to:(...)
(xxiiiA) the provision of maternity allowances, widows’ pensions, child endowment, unemployment,
pharmaceutical, sickness and hospital benefits, medical and dental services (but not so as to
authorise any form of civil conscription), benefits to students and family allowances.”
This has been interpreted to mean that although the Government can make law regarding the payment
of benefits for medical and dental services, it has no authority to control the amount doctors charge for
their services as this would amount to civil conscription. Doctors are free to determine their own value
for the health services they provide. This means that doctors are under no obligation to charge the MBS
fee set by the Government [17].
Patients can also elect to be treated as private patients. As such, patients can be treated by a medical
practitioner of their choice. Private patients must pay hospital accommodation charges and medical fees.
Hospital accommodation charges are covered by private health insurance. Medicare pays a rebate of 75%
of the MBS fee for medical services provided to private patients. Health insurance funds are required to
cover the 25% gap between the rebate and MBS fee and can also cover out-of-pocket costs between the
MBS and actual fee charged.
1.1.2 Private health insurance
Private health insurance in Australia is highly political and changes of government have usually been
accompanied by significant changes in the design of health insurance arrangements.
A number of studies have shown that private health insurance is unevenly distributed in the popula-
tion: those with private health insurance are wealthier, better educated and older than those uninsured.
As a consequence, rebates and subsidies to health insurance are inherently inequitable: the wealthy
benefit more from the subsidy.
6
Structure and regulation of the private health insurance industry
The private health insurance industry is highly concentrated, five funds (out of 30) account for more
than 70% of all insured individuals.
The industry is highly regulated. The regulatory framework for private health insurance is currently
contained in the Commonwealth Private Health Insurance Act.
The industry is subject to regulation by two bodies: the Australian Prudential Regulation Author-
ity (APRA) and the Private Health Insurance Ombudsman (PHIO). In addition, the private health APRA
PHIOinsurance industry is subject to normal trade practise laws and is thus monitored by the Australian
Competition and Consumer Commission (ACCC) in common with other industries. ACCC
In 2003, the Organisation for Economic Co-operation and Development (OECD [19]) published a OECD
review of health insurance in Australia. It reached this conclusion which still remains through after 15
years:
Private health funds have not effectively engaged in cost controls. They seem to have limited
tools and few incentives to promote cost-efficient care. Private Health Insurance (PHI) appears to PHI
have led to an overall increase in health utilisation in Australia as there are limited constraints on
expenditure growth. Insurers are not exposed to the risk of managing the entire continuum of care.
The Medicare subsidy to private in-hospital Policies to reduce medical gaps have led to some price
increase and may have enhanced supply-side moral hazard incentives. Finally, the rebate on PHI
premiums has posed pressures on public cost, as it represents tax resources that have alternative
uses.
1.1.3 Hospital treatment and services
Patients receiving treatment in hospital can be categorised as admitted or non-admitted patients. An
admitted patient (or inpatient) is a patient who undergoes a hospital’s admission process to receive admitted
patienttreatment and/or care. Patient admissions are further subdivided into overnight admissions (those
overnightrequiring at least one night of treatment) and same-day admissions (admissions that finished on the same same-day
date of admission). A non-admitted patient is a patient who does not undergo the formal admission non-admitted
patientprocess of a hospital. Non-admitted care may include outpatient visits and emergency department
services. Outpatient service is a hospital service in which patients receive treatment without being outpatient ser-
viceadmitted. Classification of certain services as ‘outpatient’ varies between hospitals [20].
The scope of our research is admitted patient care only.
1.2 Australian hospital administrative data
As discussed by Michel and Jackson [21], collections of routine, or administrative, hospital data have
many applications in healthcare. Administrative data has been seen primarily as a funding and billing
tool to assist with reimbursement of hospitals for services provided. Nowadays, hospital administrative
data has been recognised as an important resource for a range of health system improvement processes
beyond funding. A sample of the studies conducted in Australia using administrative data in healthcare
improvement are listed below [21].
i) Patient safety and quality.
ii) Injury surveillance.
iii) Incidence and burden of disease.
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iv) Clinical outcomes research.
v) Health economics research.
In our research, we had access to the Hospital Casemix Protocol inpatient dataset from an Australian
private health insurer.
1.2.1 Hospital casemix protocol inpatient dataset
The Hospital Casemix Protocol (HCP) inpatient dataset (henceforth, HCP data) is a valuable source of
information for the Australian private health industry. It includes clinical, demographic and financial
information for privately insured admitted patient services. This dataset also has episodic, benefit and
charge data for privately insured admitted patients episodes nationally since June 1996 [13]. Most
importantly, this dataset is unique.
The HCP data exhibits the following limitations.
i) It was designed for payment and funding of healthcare for privately insured admitted patients.
ii) Outcomes measurement is not their primary purpose.
Nonetheless, the HCP data stores up to 50 diagnosis conditions among other information. These
diagnosis conditions are coded using the International Classification of Diseases, 10th revision, Australian
modification (ICD10-AM) [13].
1.3 The international classification of diseases
To produce statistics on causes of illness and causes of death, parallel sets of information are needed.
For illnesses, we would need a source of morbidity data, a classification of diseases, and guidelines for
designating a principal condition from among several that may be listed on a medical record. For deaths,
we would need some form of death report, a disease classification, and a set of rules for selecting a single
cause of death for the deceased.
Historically, in order to produce comparable cause-of-death statistics, development of a disease classi-
fication was needed so that information collected in death registration could be grouped and displayed in
a similar way in different places. This necessity stimulated the continued international initiatives on the
classification of diseases that laid the groundwork of the International Classification of Diseases (ICD)
[22].ICD
The use of ICD has expanded from statistical purposes to other areas, principally indexing hospital
records and medical reimbursement.
For precision in reporting causes of illness or death, a nomenclature of diseases is essential. Anomenclature
of diseases nomenclature is a list of acceptable or approved disease terminology and differs from a classification
classification of
diseases of diseases, which refers to disease terms organized in a systematic way. The ICD provides both a
nomenclature and a classification.
As it can be found in [14], the ICD has been revised and published in a series of editions to reflect
advances in health and medical science over time. The 10th version of the ICD, ICD10, was endorsedICD10
in May 1990 by the Forty-third World Health Assembly; it is cited by more than 20,000 scientific articles
and used by more than 100 countries around the world.
The ICD is used for monitoring of the incidence and prevalence of diseases, observing reimbursements
and resource allocation trends and keeping track of safety and quality guidelines. It is also used for the
counting of deaths as well as diseases, injuries, symptoms, reasons for encounter, factor that influence
health status and external causes of disease.
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1.3.1 International classification of diseases, 10th Revision, Australian mod-
ification
ICD10-AM is the International Classification of Diseases, Tenth Revision, Australian Modification [15].
ICD10-AM is a version derived from the World Health Organization ICD10. It uses an alphanumeric
coding scheme for diseases and external causes of injury. It is structured by body system and aetiology,
comprising three, four and five character categories, ranging from general to more specific. ICD10-AM
is updated on a regular basis, with the regular updates of ICD10 being included as part of the updating
process. Table 1.1 shows some examples of the diagnosis codes used in ICD10-AM.
Diagnosis code Code description
(ICD10-AM)
T55 Toxic effect of soaps and detergents
I828 Embolism and thrombosis of other specified veins
M4504 Ankylosing spondylitis, thoracic region
Table 1.1: Example of Diagnosis codes used in ICD10-AM.
As mentioned before, in Australia, to access the ICD10-AM codes that affected the patient on a
particular admission, we need to use HCP data. The HCP data includes up to 50 columns for diagnosis
which must be coded using the most recent version of ICD10-AM. Using these 50 columns as well as the
age and gender of the patient, we will define our patient health profile.
1.4 Clinical classification of diseases
Let us recall from the beginning of this chapter that we are interested in developing a patient health
profile. Furthermore, this patient health profile should take into account the different diagnosis condi-
tions that have been captured in the HCP data and coded using the ICD10-AM. To obtain a clinically
meaningful and statistically stable health profile, we need to group the thousands of ICD10-AM codes
into a smaller number of organised categories.
In this section we present three clinical classifications of ICD10 codes that will help us define our
patient health profile.
1.4.1 Charlson conditions
In 1987, M. E. Charlson et al. [23] defined numerous clinical conditions and assessed their relevance
in the prediction of 1-year mortality. These clinical conditions were broad groupings of more specific
ones. Their objective was to develop a prognostic taxonomy for comorbid conditions which singly or in
combination might alter the risk of short term mortality for patients enrolled in longitudinal studies. A
weighted score was assigned to each of the 19 comorbid conditions introduced; the score was based on
the relative risk of 1-year mortality. These scores were then combined into a single index of comorbidity,
called the Charlson index.
Originally, Charlson et al. used clinical conditions recorded in charts to produce their list of comorbid
conditions. A coding algorithm was needed in order to relate Charlson conditions with ICD codes. In coding algo-
rithmthis context, a coding algorithm is the grouping of ICD codes into specific conditions. In 1992, a coding
algorithm using the ICD9-CM was developed for each of the variables in the Charlson index, see [24, 25]
and references therein. ICD9-CM stands for the ICD, Ninth Revision, Clinical Modification, which is ICD9-CM
the US adaptation of ICD9. ICD9
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The coding algorithm introduced in [24] is of interest to us. Quan et al. developed a coding algorithm
(see table 1.2) that uses ICD10 codes. Since our datasets are coded with ICD10-AM, the translation
between ICD10 and ICD10-AM is straightforward.
Charlson Comorbidities ICD10 Coding algorithm
Myocardial infarction I21.x, I22.x, I25.2
Congestive heart failure I09.9, I11.0, I13.0, I13.2, I25.5, I42.0,
I42.5-I42.9, I43.x, I50.x, P29.0
Table 1.2: Extract of coding algorithm developed by Quan et al. for Charlson conditions.
1.4.2 Elixhauser conditions
In 1998, Elixhauser et al. [26] introduced their own list of 31 comorbid conditions while working with
ICD9-CM coded data. Previous works before Elixhauser’s suffer from the following:
i) they didn’t take into account the complexity of ICD9-CM coding and coding idiosyncrasies in
defining comorbidities;
ii) when considering different populations they didn’t alter weighted scores for each of the comorbid
conditions; and
iii) Charlson conditions were designed to predict mortality. So, if another outcome is to be predicted,
then the weights should be re-evaluated and they didn’t.
Elixhauser’s list of 31 comorbid conditions was developed to predict hospital charges, length of stay
and in-hospital mortality. No attempt was made to combine them into a single index.
In 2016, Toson et al. [27] analysed a dataset encoded with ICD10-AM and identified Elixhauser
conditions using the coding algorithm developed by Quan et al. [24]; an example is depicted in table 1.3.
Elixhauser Comorbidities ICD10 Coding algorithm
Diabetes, uncomplicated E10.0, E10.1, E10.9,E11.0, E11.1, E11.9, E12.0, E12.1, E12.9,
E13.0, E13.1, E13.9, E14.0, E14.1, E14.9
Renal failure I12.0, I13.1, N18.x, N19.x, N25.0, Z49.0-Z49.2, Z94.0, Z99.2
Table 1.3: Extract of coding algorithm developed by Quan et al. for Elixhauser conditions.
1.4.3 The United States’ department of health and human services - hierar-
chical clinical conditions
Unless otherwise stated, the information in this section was obtained from [6].
In the US, the Affordable Care Act (ACA), sometimes known as “Obamacare”, was signed on 23ACA
March 2010. The ACA established a permanent risk adjustment programme to minimise the negative
effects of adverse selection and help level the playing field between insurance companies. The ACA
authorises the Department of Health and Human Services (HHS) to utilise criteria methods similar toHHS
those utilised under Medicare to implement risk adjustment.
According to [28], risk adjustment is defined as a statistical process that takes into account therisk adjust-
ment in the
US
underlying health status and health spending of the enrollees in an insurance plan when looking at their
healthcare outcomes or healthcare costs.
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At the heart of the HHS risk adjustment methodology is the clinical classification system that or-
ganizes the thousands of ICD10-CM codes into a coherent system of diagnostic categories. The HHS
clinical classification system was based on the Centers for Medicare and Medicaid Services Hierarchical
Condition Categories (CMS-HCC) clinical classification [29]. CMS-HCC
The Department of Health and Human Services - Hierarchical Clinical Conditions (HHS-HCC) diag-
nostic classification system begins by classifying all ICD10-CM codes into Diagnostic Groups, or DXGs. DXG
Each ICD10-CM code maps exactly to one DXG which represents a well-specified medical condition or
set of conditions, such as the DXG for Type II Diabetes with Ketoacidosis or Coma. DXGs are further
aggregated into Condition Categories (CCs). CCs describe a broader set of similar diseases. Diseases CC
within a CC are related clinically and with respect to cost. An example is the CC for Diabetes with
Acute Complications, which includes in addition to the DXG for Type II Diabetes with Ketoacidosis or
Coma, also the DXGs for Type I Diabetes and Secondary Diabetes each with ketoacidosis or coma.
Hierarchies are imposed among related CCs, so that a person is coded for only the most severe
manifestation among related diseases. After imposing hierarchies, CCs become Hierarchical Condition
Categories (HCCs). For example, diabetes diagnosis codes are organised in the Diabetes hierarchy HCC
consisting of three CCs arranged in descending order of clinical severity and cost:
i) Diabetes with Acute Complications,
ii) Diabetes with Chronic Complications and
iii) Diabetes without complications.
Thus, a person with diagnosis code of Diabetes with Acute Complications is excluded from being
coded with Diabetes with Chronic Complications or Diabetes without Complication. Similary, a person
with diagnosis code of Diabetes with Chronic Complications is excluded from being coded with Diabetes
without Complication. Although HCCs reflect hierarchies among related disease categories, for unrelated
diseases, HCCs accumulate; i.e., the model is “additive”. For example, a female with both Rheumatoid
Arthritis and Breast Cancer has (at least) two separate HCCs coded, and her predicted cost will reflect
the sum of the predicted associated costs for both conditions.
The Centers for Medicare and Medicaid Services (CMS) has published step-by-step tables explaining CMS
the HHS-HCC risk adjustment methodology [7]. However, these tables include only a part of the ICD10-
CM codes that are grouped into Condition Categories (CCs). The CCs published are the ones that are
directly associated with cost in the American context. Notice that the unpublished CCs are also part of
the HHS-HCC risk adjustment model.
1.5 Comparing healthcare providers and risk adjustment
This section contains a summary of many different comparative tools and risk adjustment methodologies
that have been developed in Australia and overseas.
Our broad definition of risk adjustment follows that of [30]: “(...) the use of patient-level informa- risk adjust-
menttion to explain variation in health care spending, resource utilisation and health outcomes over a fixed
interval of time (...)”.
1.5.1 Current methodologies
Let us present here a succinct view of the most recent studies regarding the comparison of healthcare
providers and risk adjustment we have found in the literature. We start by listing a couple of Australian
examples and conclude with some overseas examples.
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Australian examples
The Royal Australasian College of Surgeons (RACS) has released several variation reports [11]. TheseRACS
reports highlighted the variations in cost, length of stay in hospital and readmissions for orthopaedic
procedures, vascular surgery, ear, nose and throat surgery, urology and general surgery. These reports
were designed to stimulate debate on the causes of the variation; no attempts were made to risk-adjust
the surgical outcome indicators presented.
In the RACS report titled “Surgical Variance Report - General Surgery” from 2016, the first section
corresponds to Laparoscopic cholecystectomy procedures. To fully understand the variation of these
procedures, the reader must go through eleven figures representing the statistical analysis performed on
eleven outcome indicators of interest. There are 8 sections for different surgical procedures and 80 figures
to go through in total.
Among the risk-adjusted studies performed using Australian datasets, the technical supplement from
the Grattan Institute [1] describes their risk adjustment methodology. Not only patient-level information
was used (called patient factors) but they also considered provider-level information (called providerpatient factors
provider
factors
factors). The authors analysed how these factors can explain the variation in costs in different service
groups (e.g.: orthopaedics, obstetrics, urology, among others). They used a linear regression model (see
Appendix B).
Another Australian study was performed by the Independent Hospital Pricing Authority IHPA, theIHPA
IHPA is an independent Australian government agency established by the Commonwealth as part of the
National Health Reform Act 2011 [31]. Their aim was to predict the probability of a specific Hospital
Acquired Complication (HAC) occurring within an episode of care. They used a logistic linear regressionHAC
model [5].
Overseas examples
Pross et al. [32] have identified similarities and disparities between countries and initiatives for reporting
on hospital quality accountability in England, Germany, the Netherlands, Sweden and the United States.
They argued that the underlying framework includes three elements: measuring quality, reporting quality
and rewarding quality. Measuring strategies are more similar across countries, while quality reporting and
financial rewards are more dissimilar. Reporting of process indicators is more prevalent than reporting
of outcomes.
Here, a process indicator measures what a provider does to maintain or improve health, theseprocess indica-
tor measures typically reflect generally accepted recommendations for clinical practise (e.g. percentage of
people with diabetes who had their blood sugar tested and controlled). Whereas an outcome indicator
reflects the impact of the health care service or intervention on the health status of patients (e.g.: rateoutcome indi-
cator of surgical complications or infections acquired while admitted to hospital) [33].
Pross et al. [32] discussed that reporting and rewarding of quality should focus on outcome indica-
tors over process indicators. Their reasoning is as follows: while adherence to treatment protocols can
contribute to positive outcomes, outcomes achieved by following the same protocol may still differ sub-
stantially due to factors outside the protocol. They also noted that the quality-related payment scheme
from the US is the most comprehensive approach.
In the US, the Department of Health and Human Services (HHS) risk adjustment model uses an
individual’s demographic data and diagnoses to determine a risk score, which is a relative measure of
how costly that individual is anticipated to be during the year [6]. They used a linear regression model
to calculate the risk score.
Also in the US, 3M Health Information Systems has developed the 3M Clinical Risk Groups (CRGs).CRG
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The 3M CRGs are a population classification system, each 3M CRG represents a clinically meaningful
group of individuals who require similar amounts and types of resources. This is a categorical model
not a regression one. Meaning, for example, that any predictions made to, say, the length of stay of a
patient are done by knowing first in which CRG the patient belongs to and then calculating the average
of the length of stay of every other patient in the same CRG [8].
1.5.2 Potentially useful methodologies
This Section will present two techniques, namely matching methods and clustering techniques. These
two techniques can be used for making comparisons among healthcare providers. We also present our
reasons for not choosing either one. Instead, we developed a methodology that can be consider as an
outlier detection algorithm. Thus, it is only natural that we include a brief summary of these types.
Matching methods
Matching methods is an approach that could be used for comparing outcomes across healthcare matching
methodsproviders. A matching method begins by stratifying the patients that two healthcare providers have
seen into a control group - patients seen by provider 1, and a treatment group - patients seen control group
treatment
group
by provider 2. Then it matches patients across groups based on alike characteristics [34, 35]. The
matching process works by accounting for outcome variation that might be described by the covariates
(characteristics) that were matched within and between groups.
For each pair of healthcare providers the following scenarios might occur.
i) No patients from the treatment group could be matched with any patients from the control group.
ii) Some patients from the treatment group were matched with some patients from the control group.
If Scenario i) occurs, we would say that the two healthcare providers cannot be compared. If Scenario
ii) occurs, we would be able to analyse the difference in, for example, length of stay between the matched
groups to see if there are any significant differences.
We identified the following issues when considering this methodology.
M1) Not scalable. Our dataset contains 743 surgeons who have performed at least 5 surgeries in 2014.
Considering only one pair of healthcare providers at a time will be highly time consuming.
M2) Lack of transitivity. Consider the following, if provider A is found to perform better than provider
B and provider B is found to perform better than provider C, can we say that provider A performs
better than provider C? To answer this question, first we need to see in which scenario A and C
fall into (i or ii). Next, if A and C can be compared (Scenario ii), it is possible that C is actually
performing better than A. Thus, a possible ranking of healthcare providers under this setting might
not be transitive. In turn, such a ranking will be difficult to understand or follow depending on
the target audience.
We also want to point out that an important feature of matching methods is the covariate selection
[36, 37]. None of the references we found regarding matching methods have considered this nor have they
discussed the potential bias that has been introduced by not selecting an appropriate set of covariates.
Clustering techniques
Clustering techniques is a second approach that could be used for comparing outcomes across medical clustering tech-
niquesproviders. In healthcare, clustering is undertaken by grouping patients into different strata or categories,
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according to similar attributes [9]. Several clustering algorithms have been produced in healthcare
settings, with approaches specifically tailored to the data and relationships being described [9, 38, 39, 40].
Applied to our setting and given the patient population, a clustering algorithm identifies several
groups or clusters of patients with similar characteristics across each surgery or procedural intervention.
Patient outcomes could then be compared within clusters to determine what explanatory variables might
account for the observed differences. With aggregation at the medical provider level, we would then be
able to make comparisons across providers.
However, there are many difficulties and issues when considering this methodology, and accordingly,
it is not used in this work. Some of these are discussed below.
C1) Most clustering algorithms require to choose a priori the total number of clusters that need to be
found. The choice of an appropriate number of clusters is always a very difficult problem.
C2) The majority of clustering algorithms generate non-overlapping clusters. This naturally creates
some artificial boundaries between patients. Thus, patients close to one of the artificially created
boundaries will be compared against patients with a larger degree of dissimilarity.
C3) Clustering algorithms that generate overlapping clusters do exists [9]. Under this setting, if a
patient belongs to multiple clusters, which cluster do we use when doing comparisons and why?
Should we consider every cluster and create a combined comparison?
Outlier detection algorithms
An outlier is an observation or measurement that is different with respect to the other values containedoutlier
in a given dataset. Distribution-based, clustering, and density-based methods are commonly found
approaches in the literature for outlier detection [41, 42].
Distribution-based methods are typically found in statistics textbooks [42]. They apply somedistribution-
based methods standard distribution model (Normal, Poisson, etc.) and flags as outliers those data points which deviate
from the model. However, most distribution models are univariate, that is, they have few degrees of
freedom. Thus, they are unsuitable for moderately high dimensional datasets. Furthermore, for arbitrary
datasets without any prior knowledge of the distribution of points, to determine which model best fits
the data can have high computational cost and may not produce satisfactory results.
Clustering is a basic method to detect potential outliers. Potential outliers are data points whichclustering
are not located in any cluster or group. Furthermore, if a cluster differs significantly from other clusters,
the objects in this cluster might be outliers. However, since the main objective of a clustering algorithm
is to find clusters, they are not developed to optimise outlier detection. The outliers are typically just
tolerated or ignored. Even if the outliers are not ignored, the notions of outliers are essentially binary
and there are no qualifications as to how outlying an object is [42].
Density-based methods assign to each data point a degree to be an outlier. This degree is calleddensity-based
methods the local outlier factor of an object (LOF). It is called “local” because the degree depends on how
local outlier
factor (LOF) isolated the object is with respect to the surrounding neighbourhood. Outliers are data points with
high LOF values while data points with low LOF values are likely to be typical with respect to their
neighbourhood. High LOF is an indication of low-density neighbourhood and hence high potential of
being outlier [42].
Here our selected methodology can be described using the framework presented in [43]. The pa-
per [43] started with a comprehensive survey of outlier detection algorithms and proposed a theoretical
framework to local outlier detection. Their framework generalises many approaches found in the litera-
ture. Distribution-based methods, clustering and density-based methods can all be described using their
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framework. Nonetheless, in a later chapter we will present our methodology without explicitly using this
theoretical framework. Our decision was made in order to improve readability.
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Chapter 2
Datasets
This chapter provides very detailed descriptions of the datasets used and/or developed for our analysis
in subsequent chapters.
First, we clarify that in this work a separation has the same meaning as a patient admission. In separation
other words, a separation represents the entire episode of care a patient had while admitted to hospital.
A separation does not necessarily involve a surgery.
2.1 Dataset A: Orthopaedics dataset at separation level
As a case study for our research, we considered the orthopaedics dataset provided by one of the largest pri-
vate health insurers of Australia. It contained one year worth of data (calendar year 2014). Patients had
one of the following ten surgeries: hip replacement, hip revision, knee anterior cruciate ligament (ACL) ACL
repair, knee arthroscopy, knee replacement, knee revision, shoulder acromioplasty, shoulder arthroscopy,
shoulder replacement and shoulder revision.
Several outcome indicators were provided. We later grouped these indicators into specific categories
inspired by the six aims introduced by the Institute of Medicine (IOM); see Appendix A. This classifi- IOM
cation will be explained in detail in the next chapter.
For each separation the following information was available and used for our research.
i) Four identifier (ID) fields: separation ID, principal surgeon ID, hospital ID and patient ID. To ID
ensure that the privacy of patients and providers has not been compromised, no keys for identifying
patients, surgeons or hospitals were provided.
ii) Surgery the patient was admitted for.
iii) Age and gender of the patient.
iv) Length of stay in days. A value of zero was given to same day admissions.
v) Number of medical services billed by the principal surgeon, denoted as MBS items, where MBS
stands for Medicare Benefits Schedule. Medical services are defined by the MBS.
vi) Binary indicator flagging the presence of a Hospital Acquired Complication (HAC). A HAC refers
to a complication for which clinical risk mitigation strategies may reduce (but not necessarily
eliminate) the risk of that complication occurring. The Australian national list of HACs can be
found at [44]. Since this binary indicator was already provided in the dataset, we were not able to
assess which complications were included or excluded.
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vii) Binary indicator flagging referrals to Intensive Care Unit (ICU) (a value of one means that the ICU
patient was referred to ICU).
viii) Binary indicator flagging if there was a re-operation on the same area after six months of the
current separation.
ix) Binary indicator flagging if there was an unplanned readmission 30 days after the discharge of
the current separation. Examples of planned readmissions which did not activate this flag: renal
dialysis, chemotherapy and radiotherapy.
x) Binary indicator flagging an overnight separation (a value of zero meant that the current separation
was a same day admission).
xi) Six different charge amounts as described below.
a. Medical out-of-pocket (OOP) amount from providers other than the principal surgeon: thisOOP
is the reported amount of money the patient had to pay to medical providers other than the
principal surgeon.
b. Medical out-of-pocket amount from the principal surgeon: this is the reported amount of
money the patient had to pay to the principal surgeon.
c. Prostheses charge amount: amount charged for any prostheses equipment/devices used.
d. Total charge amount: total amount charged for the entire episode of care; this figure included
medical and hospital charges.
e. Total medical charge amount: total amount charged for medical services only.
f. Total MBS charge amount: this is the total amount of the MBS fees. Each medical service
has an MBS fee associated to it (see Section 1.1.1).
Let us provide a broad profile of Dataset A.
Number of Proportion (%) of separations within surgery with
Surgery separations HACs ICU Re-operations Re-admissions Overnight
usage flags
Hip replacement 4,473 1.63 3.40 2.73 7.91 99.98
Hip revision 472 4.45 20.13 8.90 15.89 99.79
Knee arthroscopy 12,016 0.17 0.075 2.73 3.64 14.93
Knee replacement 6,139 1.47 2.36 3.58 8.26 99.95
Knee ACL repair 1,774 0.11 0 0.06 2.03 88.05
Knee revision 476 3.36 5.67 5.88 13.66 100
Shoulder acromioplasty 4,077 0.12 0.29 2.01 3.63 93.08
Shoulder replacement 585 1.20 4.27 1.71 9.23 100
Shoulder arthroscopy 487 0.82 0 3.49 7.19 91.58
Shoulder revision 63 4.76 3.17 4.76 15.87 100
Total 30,562
Table 2.1: Summary information by surgery of Dataset A. Binary indicators only.
Table 2.1 shows that the most frequent surgery in our dataset was knee arthroscopy. A knee
arthroscopy is usually a same day procedure [45, 46], this explains the low proportion of overnight
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flags. In general, hip, knee and shoulder revisions are the least frequent surgical procedures. Nonethe-
less, they have the highest proportions of HACs, ICUs, re-operations and re-admissions. This shouldn’t
come as a surprise since they are more complex procedures. The most frequent reasons for revisions are
repetitive dislocation, mechanical failure (implant wear and tear, loosening, breakage) and infection [47].
The following graph shows the proportion of surgery types in a bar graph. There were only 63
separations related to shoulder revisions (less than 0.2%); this is why they are really hard to spot in
Figure 2.1.
Figure 2.1: Distribution of surgical procedures in our entire dataset. There were 30,562 separations in
total.
Average Proportion of
Surgery Length of stay Patient age male patients
(in days) (in years) (%)
Hip replacement 5.7 68.2 45.90
Hip revision 11.1 70.7 44.49
Knee ACL repair 1 29.3 64.71
Knee arthroscopy 0.3 53.2 54.79
Knee replacement 5.9 69.1 41.18
Knee revision 9.1 68.8 46.85
Shoulder acromioplasty 1.3 59.2 55.29
Shoulder arthroscopy 1.7 56.9 55.44
Shoulder replacement 4.7 72.7 36.58
Shoulder revision 5.1 70.4 36.51
Table 2.2: Summary information by surgery of Dataset A. Patient’s gender, age and length of stay only.
Table 2.2 shows that the surgeries which required the longest stay in hospital were revisions followed
up by replacements. The average patient age for a knee ACL repair is the lowest (29.3 years). The
incidence of an ACL injury is higher in people who participate in high-risk sports, such as basketball,
skiing and soccer [48].
Table 2.3 shows that the OOP costs charged by the principal surgeon are larger, on average, than the
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Average costs (in A$)
Surgery OOP from other OOP from Prostheses Total
than principal surgeon principal surgeon
Hip replacement 268 684 10,767 27.340
Hip revision 307 496 10,396 37,106
Knee ACL repair 222 876 1,277 7,901
Knee arthroscopy 79 320 35 3,983
Knee replacement 258 644 8,399 22,758.02
Knee revision 274 493 10,478 28,488
Shoulder acromioplasty 165 600 906 7,624
Shoulder arthroscopy 121 467 471 7,443
Shoulder replacement 340 929 11,197 25,234
Shoulder revision 280 439 8,263 22,483
Table 2.3: Summary information by surgery of Dataset A. Average costs only.
OOP costs charged by other medical providers involved on a given separation. On average, replacement
and revision surgeries are the most expensive in terms of prostheses charges and total costs.
Throughout this chapter, any aggregation performed at national level was performed by analysingnational level
our entire Dataset A. For example, given our dataset and Table 2.3, the national average cost of a knee
arthroscopy was A$3,983 in 2014.
From Table 2.4 we see that only 27 out of 201 hospitals (or 13%) performed all 10 surgeries in 2014.
Regarding the total number of surgeries, 88 hospitals (or 43.7%) performed more than 100 surgeries
while 43 hospitals (or 21.4%) performed less than 20. These figures warn us against comparing hospitals
with different casemix of surgeries.
Table 2.4 shows that the number of surgeons identified as principal surgeons in Dataset A varies
across states (ACT stands for Australian Capital Territory). About one third of these surgeons (264ACT
out of 915) have claimed medical services concentrating in one body location only (either hip, knee or
shoulder).
Let us select one hospital and call it Hospital 1. By comparing Figures 2.1 and 2.2, we can see the
distribution of surgical procedures of Hospital 1 is very similar to the national one. The main differences
lie in the shoulder related surgical procedures.
Refer to Figure 2.3. Let us take a look at the scatter plot of the total medical charge of the separation
(y values) against the length of stay (x values). We expect to see an overall increasing trend: the more
time spent in hospital the higher the total medical charge.
Figure 2.3 exhibits the expected trend. There is however a more interesting trend that this graph
fails to show: the ratio between the total medical charge and the total MBS charge amounts is often
greater than 1. Remember from Section 1.1.1 that in the Australian context the medical charges are not
capped. Thus, in ideal circumstances, the ratio between the total medical charge and the total MBS
charge amounts should be close to 1.
Figure 2.4 shows a worrying trend. For patients who stayed in hospital for less than 15 days, the
variability in medical relative costs is very large. To put this variation in context, let us recall that
when a patient is seen as a private patient in a hospital, 75% of the MBS fee is paid by Medicare and
at least 25% of the MBS fee is paid by the private insurer; the latter depends on the cover type and the
procedure. Let us consider two hypothetical scenarios.
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State
ACT NSW NT QLD SA TAS VIC WA Total
Hospitals
Total ≤i 5 65 ≤ 5 41 29 7 40 22 201
Performed all 10 surgeries ≤ 5 6 · ≤ 5 ≤ 5 ≤ 5 9 ≤ 5 27
With more than 100 surgeries ≤ 5 17 ≤ 5 22 8 ≤ 5 21 14 88
With less than 20 surgeries · 15 · 8 6 ≤ 5 6 ≤ 5 43
Principal surgeons
Total 21 276 13 180 68 20 202 135 915
Claimed on one body location 7 89 10 46 16 ≤ 5 59 36 264
Claimed on all body locations ≤ 5 46 ≤ 5 65 17 14 61 35 241
Surgeries
Total 569 5,627 254 7,313 2,669 1,022 8,297 4,362 30,113∗
Hip replacement 101 851 19 878 316 225 1,450 558 4,398
Hip revision 8 103 1 108 30 11 147 53 461
Knee ACL repair 43 402 9 468 140 31 408 265 1,766
Knee arthroscopy 189 1,937 176 2,871 1,348 417 3,198 1,687 11,823
Knee replacement 120 1,355 21 1,635 401 213 1,560 770 6,075
Knee revision 9 110 · 125 50 11 112 57 474
Shoulder acromioplasty 87 616 21 988 291 89 1,055 849 3,996
Shoulder arthroscopy 3 95 4 67 38 11 223 44 485
Shoulder replacement 7 143 3 167 50 10 126 66 572
Shoulder revision 2 15 · 6 5 4 18 13 63
Table 2.4: Number of hospitals, principal surgeons and surgeries by state (from Dataset A).
i Lesser or equal.
∗ There were 449 separations with missing State information.
Figure 2.2: Distribution of surgical procedures in Hospital 1. There were more than 200 separations
performed in this hospital.
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Figure 2.3: Total medical charge amount vs length of stay - national level (30,562 separations).
Figure 2.4: Total medical relative cost vs length of stay - national level (30,562 separations). Dotted line
represents a medical relative cost of 1.
i) A patient is covered for up to 1.75 times the MBS fee by his Private Health Insurer (PHI) and
Medicare. A relative cost of 2 means that the patient has to pay an out-of-pocket amount of at
least 25% of the MBS fee.
ii) A patient is covered for no more than the actual MBS fee by his PHI and Medicare. A relative
cost of 4 means that the patient has to pay an out-of-pocket amount of at least 3 times the MBS
fee.
Figures 2.5 and 2.6 show the same trends at hospital level. We can see that in Hospital 1 the medical
relative cost was contained below 2.
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Figure 2.5: Total medical charge amount vs length of stay for Hospital 1 (more than 200 separations).
Figure 2.6: Total medical relative cost vs length of stay for Hospital 1 (more than 200 separations).
Dotted line represents a medical relative cost of 1.
Comparing medical out-of-pocket amounts between different hospitals
Since we have identified a large variation in relative medical costs, a valid question we could ask ourselves
is if this variation is related to the surgical procedures performed. Let us try to find an answer to this
question by comparing Hospital 1 against two other hospitals we called Hospital 2 and Hospital 3.
From Figure 2.7 we are tempted to conclude that the total medical out-of-pocket (OOP) amount of
Hospital 2 will be the smallest while the OOP amount of either Hospital 1 or Hospital 3 will be the
largest. This assumption was made by noticing the following:
i) Hospital 2 has the lowest volume of separations; and
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Figure 2.7: Surgical procedures performed by three different hospitals. Hospitals 1 and 3 performed
more than 200 separations while Hospital 2 performed less than 200 separations.
ii) in Hospital 2, the proportion of separations related to replacement and revision surgeries, which
are known to require longer lengths of stay than the other procedures [45, 49], is also the lowest
sitting just below 30%.
Figure 2.8: Comparing three hospitals total medical out-of-pocket amount and average medical out-of-
pocket per separation split by type of specialist: principal surgeon in red and other medical providers
in orange. Hospitals 1 and 3 performed more than 200 separations while Hospital 2 performed less than
200 separations.
Figure 2.8 is quite surprising. Hospital 2 has in fact the highest OOP per separation and a total
OOP that is considerably larger than Hospital 1. The difference between Hospital 1 and Hospital 3 is
also quite large. This graph suggests that these differences are due to other factors that we have not
considered up to this point.
The factors we would like to include in our analysis correspond to the health and demographic
characteristics of the patient.
24
2.2 Dataset B: modified hospital casemix protocol data
Besides the Orthopaedics dataset provided (Dataset A), we had access to another one based on the
Hospital Casemix Protocol (HCP) data. Let us recall from Section 1.2.1 that, for each episode of
admitted hospital treatment for which a benefit has been paid, the HCP data specifies financial, clinical
and demographic data. For every patient admission, it includes up to 50 columns for diagnosis which
must be coded using the most recent version of the International Statistical Classification of Diseases
and Related Health Problems, Tenth Revision, Australian Modification (ICD10-AM).
The following information was also available for the entire calendar year 2014.
i) Two ID fields: separation ID and patient ID.
ii) Length of stay in days, a value of zero was given to same day admissions.
iii) Four different charge amounts as described below.
a. Total medical charge amount.
b. Total MBS fees.
c. Total medical benefit paid, amount paid by the PHI for medical services only.
d. Total charge amount, total amount charged for the entire episode of care. This figure included
medical and hospital charges.
iv) Age and gender of the patient.
v) Every ICD10-AM code recorded for the patient starting from the admission date of the current
separation and going back twelve months, including codes recorded in the current separation.
Remark: To avoid any possible identification of the patients, no admission dates or principal diagnosis
labels were provided.
Traditionally, HCP data only includes diagnosis codes of the current separation. In the design of
Dataset B, we were inspired by the risk adjustment methodology of the United States’ Department of
Health and Human Services (HHS) [6]. Their methodology considers all healthcare data for the preceding
twelve months. We aimed to do the same with our patient health profile. However, since we only had
access to private hospital admissions data, we could only consider diagnosis codes.
There were in total 890,425 separations in this dataset. Using the ID fields from Dataset B, we could
link this information with our Orthopaedics dataset of 30,562 separations. Refer to table 2.5 for a few
rows and columns extracted from Dataset B.
Separation ID Patient ID ... Age Gender Diagnosis codes
12345678 1 ... 62 M I10 J310 J324 J342 J338 R33 Y834 Y9222
22224444 1 ... 62 M D103 I10 J310 J324 J342 J338 R33 Y834 Y9222
11112222 132 ... 70 F M171
Table 2.5: Examples extracted from Dataset B.
This dataset was used for comparing different methodologies that could be used for defining the
health profile of a patient. A detail explanation of the comparisons made will be presented in Chapter
4.
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Chapter 3
Unadjusted comparisons of
healthcare providers
Data visualisation tools in healthcare vary according to the intended audience. For general public, in
the US, the Institute of Heath Metrics and Evaluation [50] uses US and worldwide data to produce
several interactive visualisations. Another example from the US, the Commonwealth Fund publishes
yearly results from their scorecard on State Health system performance [51].
Individuals with more technical background can find several dashboards that aim at providing in a
nutshell a more detailed view of the status of different health systems. In the literature, we can find
detailed descriptions for building scalable dashboards. Scalable dashboards can be used to describe scalable dash-
boardsthe status of a single facility or for a comparative analysis across numerous facilities [52].
The aforementioned visualisation tools are part of performance benchmarking. It is important to
recognise the difference between performance benchmarking and practise benchmarking. Performance performance
benchmarkingbenchmarking concentrates on calculating performance standards or benchmarks, a widely popular
practise. Practise benchmarking is concerned with establishing reasons why organisations achieve practise bench-
markingthe level of performance that they do [53].
In this chapter we present our scorecard as another tool for performance benchmarking. We must
stress that the benchmarks we calculated were obtained after analysing peers performance in the datasets
provided. No other standards were available for comparisons. Our intention is to facilitate quick com-
parisons across different healthcare providers (hospitals or specialists) that will encourage policy makers
to engage in a practise benchmarking in those areas that they seem to need it.
Visual representation of performance and quality information is not an easy task. In 2016, Zwinjnen-
berg et al. [54] examined how information presentation affects the understanding and use of information
for quality improvement. They conclude that bar charts or tables, and presenting outcomes as percent-
age of positive responders or on a 5-point scale enhances information understanding and use. They also
found that benchmark information reduces understanding. One of the less preferred visualisations are
radar plots.
Nonetheless, we strongly believe that radar plots can effectively convey meaningful information and
that healthcare professionals could benefit from familiarising with them. Our main reasons are:
i) radar plots are able to convey a large amount of information;
ii) radar plots can provide a standardised view of different indicators on one scale;
iii) radar plots are able to easily convey a standard or benchmark, as it will be shown later in this
chapter.
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In fact, our scorecard is represented with a radar plot that will clearly represent several surgical
outcome indicators. It is important to highlight that when we created the scorecard of a given separation,
we only compared it against separations that had the same surgical procedure.
Radar plots have been used in healthcare before. Saary [55] compiled a comprehensive list of refer-
ences. Nevertheless, the only reference we came across in which radar plots are used as a comparative
tool for outcome metrics was in a paper by Stafoggia et al. [56]. The authors compare intra-hospital
mortality and complications following surgical procedure for eight clinical categories of interest, namely
cardio-surgical, cerebro-vascular, scheduled surgery, orthopaedics and others. We have also found a radar
plot that seeks to compare the performance of several countries on four different indicators, the graph is
quite difficult to read [53].
There are two drawbacks typically associated with radar plots [55, 56] that we aim to address with
our approach:
D1. Missing data is usually misrepresented.
D2. The order of the variables can affect the reader’s interpretation of agent (e.g. hospital) outcomes.
This chapter describes any pre-processing performed on the dataset supplied in order for us to use
a radar plot. Once our scorecard is introduced, we will address drawbacks D1 and D2. Finally, as an
example, we will present an aggregation mechanism at hospital level that facilitates comparisons between
different hospitals.
3.1 Dataset A and outcome indicators
The dataset we used in this chapter is the one described in Section 2.1: Dataset A or Orthopaedics
dataset. Let us recall that this dataset consisted of one year worth of data (January 2014 to December
2014). Patients were admitted to hospital for one of the following ten surgical procedures: shoulder
acromioplasty, shoulder replacement, shoulder revision, shoulder arthroscopy, hip replacement, hip revi-
sion, knee replacement, knee revision, knee arthroscopy and knee ACL.
The following indicators contained in our Orthopaedics dataset are of relevance to this chapter. These
indicators fall into two categories: context indicator (CI) or outcome indicator (OI).CI, OI
CI.1 Hospital where the separation took place.
CI.2 Surgery(ies) the patient was admitted for.
CI.3 Age of the patient.
CI.4 Gender of the patient.
OI.1 Length of stay, number of days the patient stayed in hospital. The value of 0 was given to same
day admissions.
OI.2 Number of medical services billed by the principal surgeon, which is denoted by MBS Items, whereMBS Items
MBS stands for Medicare Benefits Schedule. Recall from Section 1.1.1 that the MBS determines
which medical services are eligible for Medicare funding.
OI.3 Medical out-of-pocket (OOP) amount from providers other than the principal surgeon, denoted by
Medical OOP not surgeon. This is the reported amount of money the patient had to pay toMedical OOP
not surgeon medical providers other than the principal surgeon for the hospital separation.
28
OI.4 Medical out-of-pocket amount from the principal surgeon, denoted by Medical OOP surgeon.
This is the reported amount of money the patient had to pay to the principal surgeon for theMedical OOP
surgeon hospital separation.
OI.5 Prostheses charge. Amount charged for any prostheses equipment/devices used for items on the prostheses
chargeProsthesis List published by the Australian Department of Health [57].
OI.6 Total charge. Total amount charged for the entire episode of care. This charge included medical total charge
and hospital charges.
OI.7 Hospital Acquired Complications (HAC). This was a binary flag defined already in the private
health insurance data provided to us. It flagged if any event occurred while in hospital that could
potentially increase cost of treatment or length of stay. Only 241 separations out of the 30,562
separations considered had a hospital acquired complication recorded.
OI.8 Intensive Care Unit (ICU). This was a binary flag representing if the patient was transferred to
ICU or not.
OI.9 Re-operations, denoted by 180d Reop. This was a binary flag representing if a patient had a 180d Reop
re-operation within 180 days after discharge. The re-operation had to be of the same type as the
current separation.
OI.10 Readmission within 30 days, denoted by 30d Readmit. This was a binary flag representing 30d Readmit
unplanned readmissions. Readmissions had to be of the same type as the current separation.
OI.11 Overnight flag. This was a binary flag representing if the patient stayed in hospital overnight.
At this point, it is worth noting that every context and outcome indicators were provided for this
research as is. Even though these indicators can be easily measured for other surgeries, due care regarding
their relevance is needed.
Throughout this chapter any aggregation performed at national level was carried out by analysing national level
our entire Orthopaedics dataset.
Grouping outcome indicators
As mentioned in Chapter 2, we grouped our outcome indicators into three aims (out of a total of six
aims) introduced by the Institute of Medicine (see Section A). Associations between aims and outcome
indicators are described below.
A1 Safety. OI chosen: OI.7 Hospital Acquired Complications.
Reasoning: This indicator registered several events that, in some cases, can be avoided in a safe
healthcare environment. Examples of such events are infections and falls resulting in fracture
within health service area.
A2 Effectiveness. OI chosen: OI.8 ICU flag, OI.9 Re-operations, OI.10 Readmission within 30 days
and OI.11 Overnight flag.
Reasoning: These outcome indicators are expected to be a direct reflection of any relevant evidence-
based practise.
A5 Efficiency. OI chosen: OI.1 Length of stay, OI.2 Number of medical services billed by the principal
surgeon, OI.3 Medical out-of-pocket amount from providers other than the principal surgeon, OI.4
Medical out-of-pocket amount from the principal surgeon, OI.5 Prostheses charge amount and OI.6
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Total charge amount.
Reasoning: As mentioned in Section A, there are two ways to improve efficiency: i) reduce quality
waste which can result in lower resource use; and ii) reduce administrative or production costs. In
particular, the number of medical services billed by the principal surgeon was included here since
the MBS is based on a fee-for-service approach. Such an approach can give emphasis on activity
rather than outcome, and episodic rather than coordinated, multidisciplinary care [58].
We were not able to associate the other three aims, namely patient centred, equity and timeliness with
the dataset indicators. The other three aims were not possible to directly associate with the datasets
provided. Nonetheless, two of them were considered in one way or another in our analysis.
A3 Patient Centred. We kept a context indicator, Member Age, as part of this aim.
A6 Equity. The availability of care and quality of services should be based on individuals’ particular
needs and not on personal characteristics unrelated to the patient’s condition or to the reason for
seeking care. This is why in later chapters we compare only like for like patients. If quality of care
is truly equal for everyone, any variation in outcome indicators should be minimal.
The aim A4 Timeliness was not possible for us to consider in any way with the information provided
to us.
3.2 Scorecards
Scorecards were created by using twelve of the indicators listed in the previous section: OI.1 to OI.11
and CI.3.
Since every indicator has values with different units or ranges, a radar plot with our twelve indicators
could be hard to interpret. Thus, we transformed our indicators so that each uses values between 1 and
5 inclusive. This transformation was done per surgery type. Furthermore, our transformation respects
the skewness of our data. We proceed as follows.
i) Pick a surgery type.
ii) Pick an outcome indicator, I, for that surgery.
iii) Create an array R indexed 0, . . . ,n− 1 with the n non-missing values of the indicator I. Let
R= (r0, . . . , rn−1).
iv) By removing repeated values and sorting in an increasing way, create a new array S indexed
0, . . . ,m−1 with the m distinct values of the indicator I. Let S = (s0, . . . ,sm−1) with sj−1 < sj for
every j ∈ {1, . . . ,m}.
v) Define the function F : R −→ S as F (ri) = sji , where i ∈ {0, . . . ,n− 1} and j is the unique index
j ∈ {1, . . . ,m} such that ri = sj .
vi) Using the indices of the values in S, the following formula transforms any sj value into a number
between 1 and 5 inclusive:
Tr sj = 4×
(
j
m
)
+ 1. (3.1)
The quotient in the brackets of Equation 3.1 is a number between 0 and 1 which can be interpreted
as the percentile of the value sj . By multiplying it by 4 and adding 1 afterwards, we create a
number between 1 and 5 inclusive.
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vii) We create a new array Tr R with n entries in which
Tr ri = Tr F (ri). (3.2)
We say that this array stores the scores of the outcome indicator I. scores
As an example on how we used Equations (3.1) and (3.2), consider I to be the HAC indicator for
hip replacements. This indicator was the most skewed no matter the surgery type. There were 4,473
separations. Create the initial array R,
R= (0, . . . , 0︸ ︷︷ ︸
4400 cases
, 1, . . . , 1︸ ︷︷ ︸
73 cases
). (3.3)
After removing repetitions and sorting the remaining values, we had S = (0,1) indexed with 0 and 1.
Then Tr S = (1,3). Hence Tr R is as follows
Tr R= (1, . . . , 1︸ ︷︷ ︸
4400 cases
, 3, . . . , 3︸ ︷︷ ︸
73 cases
). (3.4)
By plotting the scores of every outcome indicator in a radar plot we create our scorecard. scorecard
Figure 3.1 depicts the scorecard of a shoulder acromioplasty separation. A positive outcome is visually
represented by a small polygon closer to the centre, conversely, a negative outcome is represented by a
large polygon with vertices closer to the edge of the radar plot; in the literature it is usually the reverse
order. Certainly, “Member Age” is not an outcome indicator. It was included in the analysis to give
some context on the patients being treated; perhaps older patients have longer lengths of stay.
Figure 3.1: Example of a shoulder acromioplasty scorecard.
From the scorecard of Figure 3.1, we can see that the patient had high total and out-of-pocket charges.
Without a benchmark to compare against, we cannot say how high these charges are. The only non-zero
binary indicator is the overnight flag.
We now address the two drawbacks typically associated with radar plots mentioned at the beginning
of this chapter. Afterwards, we use these scorecards to find the median scorecard at hospital level.
Addressing drawback D1
D1. Missing data are usually misrepresented.
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Many authors use the value ‘0’ to represent missing data. This is problematic since some variables
(like Prostheses Charge) have ‘0’ as a possible value.
Recall that when creating our array R we did not take into account missing values, refer to step iii).
Also, for non-missing values, Equation 3.1 ensures that the transformed value is a number between 1
and 5 inclusive. Hence, we assign the transformed value of ‘0’ to missing values.
Figure 3.2: Example of a knee arthroscopy scorecard with a missing value.
Figure 3.2 shows a separation with a missing HAC. Every other indicator varies from 1 to 5 inclusive.
Addressing drawback D2
D2. The order of the variables can affect the objective interpretation of quantitative outcome val-
ues/variables.
(a) Shoulder acromioplasty scorecard (Figure 3.1). (b) Shoulder acromioplasty scorecard with new ordering.
Figure 3.3: Side-by-side scorecards with different orderings of indicators.
Consider the example depicted in Figure 3.1 and let us change the order of our variables. Figure 3.3b
highlights the salience of the indicators member age and overnight flag. However, this is an interpretation
32
which is buried in the data presentation found in Figure 3.1. To avoid different interpretations, we will
compare all these values against some benchmark. To this end, we calculated the median of every
transformed value per surgery type at a national level. Subsequently, we obtained ten different national
median scorecards, one for each surgery type. median score-
card
(a) Hip replacement (b) Hip revision (c) Knee ACL repair
(d) Knee arthroscopy (e) Knee replacement (f) Knee revision
(g) Shoulder acromioplasty (h) Shoulder arthroscopy (i) Shoulder replacement
(j) Shoulder revision
Figure 3.4: National median scorecards.
Figure 3.4 shows the ten national median scorecards. Notice that if one of our indicators (on a
given surgery type) was approximately normally distributed, from Equation (3.1), we would expect its
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transformed median value to be 3.
In Figure 3.5a we can see the example from Figure 3.1 with the national median scorecard for shoulder
acromioplasty juxtaposed. Our interest is immediately drawn to variables that are not only further away
from the centre but also higher than the national median. We can see that total charge is larger than
the national benchmark but this difference is not as high as the differences in out-of-pocket amounts.
Every other indicator appears to be relatively close to the national median. This interpretation does not
change if we alter the order of the variables, see Figure 3.5b.
(a) Shoulder acromioplasty scorecard vs the
national median.
(b) Shoulder acromioplasty scorecard vs the
national median with new ordering.
Figure 3.5: Example of a shoulder acromioplasty separation against the national median with two dif-
ferent orderings.
Remark: When calculating national benchmarks, we decided to work with median values for one
main reason: the median is a measure of centre that is resistant to extreme values [59].median
3.3 Hospital level scorecards
In the previous section we showed how the separation scorecards can be aggregated at a national level.
This time, we will repeat the same technique at hospital level. We selected two hospitals with substantial
activity in orthopaedics surgery and a similar proportion of activity within each procedure (see Figure
3.7). They also had a casemix of procedures similar to our entire dataset (see Figure 3.6).
Let us look now at the median scorecards of their knee arthroscopy and knee replacement separations.
This will also show any other differences regarding their performances. Figures 3.8b and 3.9b show the
median scorecards for knee arthroscopy and knee replacement respectively (the national benchmarks
have been singled out in Figures 3.8a and 3.9a). Median scorecards from Hospital 1 are well inside the
national median scorecards, while the main differences with Hospital 2 median scorecards lie in total
charges and medical out-of-pocket amounts. Both hospitals seem to behave similarly in relation to HAC,
ICU, re-operations, re-admissions, member age, length of stay and MBS items.
For any given hospital we could repeat this procedure and define a median scorecard for each surgery
type. This implies that there will be up to ten different median scorecards. Consequently, going back
and forth between the ten median scorecards at hospital level (for comparison purposes) can be quite
tedious. Thus, we looked for a simple way to consolidate the ten median scorecards of a hospital into
one.
34
Figure 3.6: Distribution of surgical procedures in our entire dataset (Figure 2.1).
Figure 3.7: Proportion of surgeries performed by Hospitals 1 and 2. Each hospital performed about 200
separations in total.
3.3.1 Consolidated scorecards
If we want to quickly assess a hospital’s current performance in all ten surgeries, reading and under-
standing all ten scorecards will be quite difficult. This section presents one way to consolidate our ten
scorecards into one.
Our consolidated scorecards were obtained after combining each median outcome indicator trans-
formed values into a single one. Recall from Section 3.2 that the transformed values of each outcome
indicator and each surgery type ranged from 0 to 5, where the lower its value the better and 0 is reserved
for missing data. The following describes the procedure for obtaining the national median consolidated
scorecard.
i) Pick one outcome indicator.
ii) For each surgery type, we computed the median of the transformed values of the outcome indicator
selected.
iii) Multiply each median calculated in ii) by the relative frequency of each surgery type. We call these
values weighted medians. weighted medi-
ans
iv) Add all the weighted medians calculated in iii).
v) Repeat ii) - iv) for every outcome indicator.
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(a) National median. (b) Hospitals 1 and 2 vs national median. Hospital 1
performed 50% more knee arthroscopies than Hospital
2.
Figure 3.8: Knee arthroscopy scorecards for two hospitals and the national median (numbers represent
separations considered).
(a) National median. (b) Hospitals 1 and 2 vs national median. Both hospitals
performed a similar number of knee replacements.
Figure 3.9: Knee replacement scorecards for two hospitals and the national median (numbers represent
separations considered).
The procedure just presented could be also done at surgeon level or hospital level. As an example,
let us consider the transformed values of Medical Charge of a made up hospital, refer to Table 3.1. We
will calculate the consolidated Medical Charge of this hospital. Table 3.1 also shows the median of the
transformed Medical Charge values.
Following steps iii) and iv) we obtained the consolidated Medical Charge of the hospital:consolidated
outcome
indicator
38
725 ×2 +
5
725 ×3 +
50
725 ×2 +
385
725 ×1 + · · ·
36
Surgery type Number of separations Median of Transformed Medical Charge
Hip Replacement 38 2
Hip Revision 5 3
Knee ACL 50 2
Knee Artrhoscopy 385 1
Knee Replacement 112 2
Knee Revision 15 2
Shoulder Acromioplasty 98 1
Shoulder Arthroscopy 12 2
Shoulder Replacement 10 2
Shoulder Revision 0 0
Total 725
Table 3.1: Number of separations and medical charge scores per surgery type of made-up hospital.
+112725 ×2 +
15
725 ×2 +
98
725 ×1 + · · ·
+ 12725 ×2 +
10
725 ×2 +
0
725 ×0≈ 1.34.
We repeat this procedure for every transformed outcome indicator. The consolidated scorecard
of the hospital is created by plotting the values of the consolidated outcome indicators in our radar plot. consolidated
scorecardIn a similar way, we calculated a national consolidated scorecard.
(a) National consolidated scorecard. (b) Consolidated scorecards for Hospitals 1 and 2 vs na-
tional consolidated scorecard.
Figure 3.10: Consolidated scorecards for two hospitals and the national median (numbers represent
separations considered).
Figure 3.10a shows the national consolidated scorecard while Figure 3.10b shows the consolidated
scorecards for Hospital 1 and Hospital 2 compared against the national consolidated scorecard. If we were
to look at the ten different median scorecards of Hospitals 1 and 2, we will draw the same conclusion as
by looking at this individual graph: the only recognisable difference between these two hospitals lies on
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cost indicators. Hospital 1 costs indicators in comparison to the national median are all lower. Whereas
Hospital 2 costs indicators are considerably higher than the national median except for prostheses charge.
Every other indicator can be considered close to the national median (with Hospital 2 overnight indicator
being somewhat larger).
This is the main value of radar plots. They enable a very quick examination of what indicators
hospitals or doctors are performing better than some benchmark or their peers. Also, by grouping
outcome indicators into domains (such as safety, effectiveness and efficiency), it also enables an assessment
of whether performance is consistently good across all indicators or there are specific areas of concern.
3.3.2 Ranking of hospitals
We present now how to rank hospitals. We use this ranking to categorise hospitals into potential low
and high performers that warrant further investigation through risk-adjusted analysis, clinical review or
other input. The hospitals we compared had at least 20 separations reported in total in our dataset.
There may be hospitals with a small number of separations within procedures (43 hospitals out of 201
hospitals were removed for this analysis).
i) Rank hospitals according to the sum of the values that were used for their consolidated scorecards.
This ensures that the order of the variables has no effect.
ii) A potentially high performing hospital will have a sum that lies in the bottom 20th percentile. The
bottom 20th percentile lies between [14.21, 17.80].
iii) A potentially low performing hospital will have a sum that lies in the top 20th percentile. The top
20th percentile lies between [21.11,27.11]
For Hospital 1, the sum of the values that are calculated from its consolidated scorecard is 16.19.
While for Hospital 2, its sum is 24.63. These figures place Hospital 1 as a potentially high performing
hospital and Hospital 2 as a potentially low performing hospital. From Figure 3.7, we know that these
hospitals have performed the same surgical procedures in a similar proportion.
Further investigation of both hospitals is required in order to conclude if they are indeed low or high
performers.
3.3.3 The 90th percentile consolidated scorecard
The consolidated scorecards created at hospital and national levels in Section 3.3.1 have one drawback.
Consider the following scenario, suppose a hospital is performing 100 surgeries with 70 of them not
having hospital acquired complications (HACs) and 30 of them having HACs. Our data states that this
is a really bad scenario. However, our median scorecards will report that the median HAC of the hospital
is 0 since they do not happen at least 50% of the time.
For this reason, we will calculate the 90th percentile consolidated scorecard. We are not only interested
in a benchmark that reflects how usually hospitals perform but also how badly they do 10 percent of the
time. This should give us a better picture of the performance of a hospital.
For calculating the 90th percentile consolidated scorecard at hospital and national level, we repeated
the steps outlined in Section 3.3.1 with a small modification.
i) Pick one outcome indicator.
ii) For each surgery type, we computed the 90th percentile of the transformed values of the outcome
indicator selected.
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iii) Multiply each value calculated in ii) by the relative frequency of each surgery type. We call these
values weighted 90th percentiles. weighted 90th
percentiles
iv) Add all the weighted 90th percentiles calculated in iii).
v) Repeat ii) - iv) for every outcome indicator.
Let us present now, how Hospitals 1 and 2 compare against the national 90th percentile consolidated
scorecard.
(a) National 90th percentile consolidated scorecard. (b) 90th percentile consolidated scorecards - Hospital 1
vs Hospital 2 vs national.
Figure 3.11: 90th percentile consolidated scorecards for two hospitals against the national one (numbers
represent separations considered).
Figure 3.11a shows the national 90th percentile consolidated scorecard while figure 3.11b shows the
consolidated 90th percentile scorecards for Hospital 1 and Hospital 2 compared against the national
scorecard. The differences in cost indicators are more evident. Hospital 1 costs indicators are all consid-
erably lower than the national 90th percentile with total charge and medical OOP from surgeon being
the lowest ones. Hospital 2 OOP indicators are still above the national ones. Hospital 2’s total charge
and prostheses charge are the same as the national 90th percentile.
By looking at Figures 3.10 and 3.11, we can see that Hospital 1 costs were either on par or considerably
better than the national median and 90th percentile. In the case of Hospital 2, their costs needed to be
examined more closely in order to find out the reasons behind this large difference.
3.4 Discussion
Radar plots provide a clear and effective comparative tool for discerning multiple outcome indicators at
different levels of aggregation. We presented scorecards at separation level in Figure 3.1, at hospital level
and at national level in Figure 3.10b. We can, just as easily, create one for each surgeon.
For creating our scorecards, since every outcome indicator has different units and distributions they
all need to be rescaled. The procedure explained in Section 3.2 not only does that but it also respects
the skewness of each indicator.
Furthermore, the national median scorecards depicted in Figure 3.4 showed that indicators with high
variability (any of the cost indicators for example) can, and will, draw the attention of the observer. To
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this end, having a scorecard compared against a benchmark reduces confusions and misinterpretations.
Our attention will always be drawn to indicators that are clearly different to the benchmark given.
We have also presented a way to consolidate our scorecards into one, refer to Figure 3.3.1. As
explained in Section 3.3.1, this was done to reduce the complexity of reading and understanding all
scorecards in a quick manner. This reduction in complexity comes at a price. For example, Figure 3.10
shows that the OOP values and total charge for Hospital 2 are of concern, but it does not show which
surgery is driving these high values. We recommend using consolidated approaches sparingly.
It can be argued that the national consolidated scorecard is influenced by the casemix at the national
level across different procedures. This influence could make the comparisons made against Hospitals 1
and 2 irrelevant. We kept our comparisons with these two hospitals ’as is’ because Hospitals 1 and 2
were chosen for having similar casemix of procedures as the national level (compare Figures 3.6 and 3.7).
In general, for creating our consolidated scorecards, we considered the relative frequency of the
surgeries to be the only weighting factor. However, we can devise complex mechanisms to set up the
weights. This mechanisms could then consider the casemix of the procedures. Furthermore, it is well
known that hip (or knee) revisions can be considerably more complicated than hip (or knee) replacement
surgeries [47]. A future line of investigation could consist of introducing this complexity into the weighting
of the surgeries.
Hospitals were ranked according to an unweighted sum of all their scores. This ensured that the order
of the indicators had no effect and that every indicator had the same importance. We could have also
ranked them by efficiency indicators only to see which hospitals seemed to be more efficient. Regardless
of the ranking mechanism chosen, once potential low and high performers are found, they need to be
further investigated through risk-adjusted analysis, clinical review or other input.
None of the data presented in these visualisations has been risk adjusted. In fact, that will be the
topic of the next chapter: Risk Adjustment.
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Chapter 4
Risk Adjustment Methodology
The previous chapter showed how variation in outcome indicators could be represented using radar plots.
This variation was obtained without performing any form of risk adjustment. We also compared the
performance of hospitals with similar casemix of procedures.
This chapter is entirely dedicated to present our risk adjustment methodology. Our aim is to compare
performance of outcome indicators of healthcare providers (hospitals or surgeons). Our preference is to
have only one approach regardless of outcome indicator, procedure, patient or provider. Therefore, we
want a benchmarking and comparison methodology that accounts for different patient characteristics in
our dataset. Thus, any variation in performance between providers should be explained by other factors
not included in our model, including provider related factors.
We start by presenting five exhaustive clinical classifications of diagnosis codes. One of these classi-
fications is chosen to define a health profile for each patient. Our decision is made after comparing the
classifications through linear regression models. Each linear regression model has as output one outcome
indicator and as inputs age-gender interaction groups and the patient diagnosis codes encoded by one of
the exhaustive clinical classifications. In total, there were 45 linear regression models performed. Refer
to Appendix B for an overview of linear regression models.
Once a patient’s health profile is defined, we present how our dataset is encoded with this new
information. Afterwards, our concept of “similar” patients is introduced. Our idea of similarity is
needed in order to establish comparison of outcomes between similar patients. As starting point, given
a patient, we highlight which of his outcome indicators, if any, are outliers. This is done by looking at
the outcome indicators of those patients who are similar to the patient.
Towards the end of this chapter we present a couple of aggregation mechanisms at surgeon level.
Comparisons at hospital level can be performed just as easily. The first mechanism allows for individual
assessment of providers by calculating a personalised benchmark and risk adjusted averages for each
provider. The second mechanism simply calculates the relative frequency of outliers each provider has.
These aggregation mechanisms are then used for ranking providers in two different ways.
We close this chapter providing a high level summary of each section which can be referred to as a
high-level guide of our risk adjustment methodology. We need to acknowledge the following limitations.
i) We are using administrative data from private hospitals to undertake risk adjustment. The datasets
used in our study do not include medical records, primary care data, pharmaceutical data or, even,
public hospital data.
ii) Due to i) we won’t be able to fully account for patient factors in creating our health profile.
iii) Once our risk adjustment methodology is applied, any variation in performance between providers
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could be explained by other external factors, namely provider factors and factors outside the control
of both provider and patient.
4.1 Exhaustive clinical classifications of diagnosis codes
This section has one purpose, namely, to find an exhaustive clinical classification which can be used for
defining the health profile of every patient. It starts by comparing the clinical classifications that were
discussed in Section 1.4. For clarity, we start with a quick overview of the clinical classification presented
earlier as well as how they are encoded in our dataset.
We follow up with the regression models we used for comparison and conclude with the clinical
classification chosen.
4.1.1 Overview and coding of clinical classifications
In Section 2.2, we presented a modified Hospital Casemix Protocol (HCP) data that we had access to,
Dataset B. It contained diagnosis codes which were coded using the International Statistical Classification
of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD10-AM). In order
to obtain clinically meaningful and statistically stable models, the thousands of ICD10-AM codes must
be grouped into a smaller number of organised categories. Thus, we require an exhaustive clinical
classification of ICD10-AM codes.
Recall from Section 1.4 the three clinical classifications of interest to us: Charlson, Elixhauser and
the HHS-HCC. Here, HHS-HCC stands for the United States’ Department of Health and Human Ser-
vices - Hierarchical Condition Categories. These three clinical classifications are not exhaustive in their
current format. Therefore, we started by completing the Charlson, Elixhauser and the partial HHS-HCC
classifications by grouping any unused ICD10-AM code into the relevant chapter in which the code fits,
according to the World Health Organization (WHO) [60].
For identifying the Charlson and Elixhauser conditions from our modified HCP data, we used the
coding algorithm developed by Quan et al. [24]. They coded each condition with ICD10 codes. The
translation between ICD10 and ICD10-AM, the Australian adaptation, was done by the private health
insurer. Notice that Quan et al. combined three of the Charlson conditions into one, hence their coding
algorithm for Charlson conditions has 17 conditions in total.
4.1.2 Completing clinical classifications of interest
We present how a partial clinical classification can be completed starting with Charlson’s classification
as an example. Before that, however, let us relabel the 17 Charlson conditions [24] as per Table 4.1. A
chapter defined by the WHO [60] is labelled by WHOXX, refer to Table 4.2.
We start by consider the following example. A patient from our modified HCP data, Patient A, is an
eighty-five year old man who had the following twenty ICD10-AM codes recorded: C672, C679, D090,
D649, E875, I2511, K590, M4793, M5485, N133, N179, N183, N40, R074, R31, R33, Z720, Z8643, Z951
and Z955. We want to match the patient’s diagnosis codes with a Charlson condition or a chapter in
WHO. In this way, every ICD10-AM code will be exhaustively classified. We used the coding algorithm
developed by Quan et al. [24] for classifying three of the twenty codes provided into two Charlson
conditions.
i) code N183 =⇒ CHARL13.
ii) codes C672 and C679 =⇒ CHARL14.
42
Charlson condition New label
Myocardial infarction CHARL01
Congestive heart failure CHARL02
Peripheral vascular disease CHARL03
Cerebrovascular disease CHARL04
Dementia CHARL05
Chronic pulmonary disease CHARL06
Rheumatic disease CHARL07
Peptic ulcer disease CHARL08
Mild liver disease CHARL09
Diabetes without chronic complication CHARL10
Diabetes with chronic complication CHARL11
Hemiplegia or paraplegia CHARL12
Renal disease CHARL13
Any malignancy, including lymphoma and leukemia, except malignant neoplasm of skin CHARL14
Moderate or severe liver disease CHARL15
Metastatic solid tumor CHARL16
Acquired Immune Deficiency Syndrome (AIDS) / Human Immunodeficiency Virus (HIV) CHARL17
Table 4.1: New labels considered for Charlson conditions.
iii) code D090 =⇒ WHO02.
iv) code D649 =⇒ WHO03.
v) code E875 =⇒ WHO04.
vi) code I2511 =⇒ WHO09.
vii) code K590 =⇒ WHO11.
viii) codes M4793 and M5485 =⇒ WHO13.
ix) codes N133, N179 and N40 =⇒ WHO14.
x) codes R074, R31 and R33 =⇒ WHO18.
xi) codes Z720, Z8643, Z951 and Z955 =⇒ WHO21.
Hence, the encoding of the patient’s diagnosis codes is
0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0︸ ︷︷ ︸
CHARL01-CHARL17
,0,1,1,1,0,0,0,0,1,0,1,0,1,1,0,0,0,1,0,0,1,0︸ ︷︷ ︸
WHO01-WHO22
.
For completing the Elixhauser classification, the conditions were relabelled as ELIX01 up to ELIX31
according to the order they appear in [24]. For the partial HHS-HCC classification, we relabelled the
clinical conditions [7] as HCC001 up to HCC107.
The tables provided by the CMS showed a way to reduce the 107 categories considered by the HHS-
HCC risk adjustment methodology down to 25 categories [7]; we labelled the groupings of this reduced
version of the HHS-HCC, called red-HCC, as MOD01 up to MOD25. red-HCC
These three clinical classifications mentioned, namely, Elixhauser, HHS-HCC and its reduced version,
all were made exhaustive by completing them with relevant chapters in WHO. In total, we have four
exhaustive clinical classifications.
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WHO Chapter New label
CH I Certain infectious and parasitic diseases WHO01
CH II Neoplasms WHO02
CH III Diseases of the blood and blood-forming organs and certain disorders WHO03
involving the immune mechanism
CH IV Endocrine, nutritional and metabolic diseases WHO04
CH V Mental and behavioural disorders WHO05
CH VI Diseases of the nervous system WHO06
CH VII Diseases of the eye and adnexa WHO07
CH VIII Diseases of the ear and mastoid process WHO08
CH IX Diseases of the circulatory system WHO09
CH X Diseases of the respiratory system WHO10
CH XI Diseases of the digestive system WHO11
CH XII Diseases of the skin and subcutaneous tissue WHO12
CH XIII Diseases of the musculoskeletal system and connective tissue WHO13
CH XIV Diseases of the genitourinary system WHO14
CH XV Pregnancy, childbirth and the puerperium WHO15
CH XVI Certain conditions originating in the perinatal period WHO16
CH XVII Congenital malformations, deformations and chromosomal WHO17
abnormalities
CH XVIII Symptoms, signs and abnormal clinical and laboratory findings, WHO18
not elsewhere classified
CH XIX Injury, poisoning and certain other consequences of external causes WHO19
CH XX External causes of morbidity and mortality WHO20
CH XXI Factors influencing health status and contact with health services WHO21
CH XXII Codes for special purposes WHO22
Table 4.2: New labels considered for WHO chapters.
4.1.3 Linear regression models - input variables
Over the years, several authors have used regression models for comparing the performance of clinical
classifications [61, 62, 63, 64]. Following their footsteps, the next section presents the comparison of
our exhaustive clinical classifications using linear regression models. Refer to Appendix B for a quick
overview of linear regression models. This section explains which input variables we used and how we
encoded our dataset.
We considered the age and gender of the patient as part of our regression models. Age and gender were
used to create fourteen gender-age group interactions, namely males (females) aged below 2, between 2
and 16, 17 and 34, 35 and 49, 50 and 64, 65 and 79 and above 80. These gender-age group interactions
were suggested by our industry partner. They are not customised by procedure so they may influence
the result. The gender-age group interaction with most cases, namely females aged between 50 and 64
years, was removed from the regression model. This was made so that the intercept with the Y-axis in
the regression model could represent the expected value of the given output variable for a female aged
between 50 and 64. Refer to Appendix B.
For each clinical classification, we added one variable for each gender-age group, one variable for each
group of the clinical classification, including the chapters defined by WHO. As an example, back to our
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Patient A from the previous section, his information was represented as follows 0,0,0,0,0,0,1,0,0,0,0,0,0︸ ︷︷ ︸
7 male-age and 6 female-age group interactions
,
0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0︸ ︷︷ ︸
CHARL01-CHARL17
,0,1,1,1,0,0,0,0,1,0,1,0,1,1,0,0,0,1,0,0,1,0︸ ︷︷ ︸
WHO01-WHO22
 .
Finally, we designed a linear regression model that consider only the WHO classification. This
regression model represented our null model. Any clinical classification be Charlson, Elixhauser, HHS-
HCC or red-HCC, had to perform just as good as the null model to be considered as a candidate for our
patient health profile.
Table 4.3 shows the input variables considered in our linear regression models.
Model Input variables Total number
of variables
Null model 13 gender - age group interactions plus 22 WHO chapters 35
Charlson 13 gender - age group interactions plus 17 Charlson conditions 52
plus 22 WHO chapters
Elixhauser 13 gender - age group interactions plus 31 Elixhauser conditions 66
plus 22 WHO chapters
HCC 13 gender - age group interactions plus 107 HCC 142
plus 22 WHO chapters
red-HCC 13 gender - age group interactions plus 25 reduced HCC 60
plus 22 WHO chapters
Table 4.3: Input variables considered in each linear regression model.
4.1.4 Linear regression models - results
In order to determine which clinical classification is used for our patient health profile we compare linear
regression models of outcome indicators of interest. We aim at selecting the clinical classification with
highest adj R-sq statistic [62] across all our models. We used the adj R-sq statistic because, by definition,
it penalises linear models with a large number of inputs, refer to Appendix B.
We work with both Datasets A and B, namely our orthopaedics dataset and our modified HCP
data, respectively. By considering a specific surgery department, namely Dataset A, we assess if any of
our clinical classification models performs differently by changing the context of the data (from a more
specific surgery department to a more “national” setting).
Table 4.4 summarises our results when considering Dataset A. Our analysis was performed at sepa-
ration level. The numbers on each cell represent the adj R-sq statistic. Notice that no infants (patients
below age 2) were present in this dataset.
Dataset B had several patients being treated more than once. Therefore, we grouped this dataset
at patient level. Recall that each patient admission had 12 months of ICD10-AM codes recorded. If a
patient was seen more than once, we only considered ICD10-AM codes of the last appearance plus the
12 months before that appearance. After grouping at patient level, the values of the outcome indicators
chosen were combined by adding them together. In fact, the HHS-HCC risk adjustment methodology
was designed after grouping relevant clinical information at patient level and combining costs by adding
them [6]. Table 4.5 summarises our results.
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Outcome Indicator Null Charlson Elixhauser HCC red-HCC
Length of stay 33.56% 34.17% 35.37% 37.64% 35.56%
Prostheses charge 28.73% 28.95% 28.66% 29.5% 29.02%
Total charge 37.39% 37.66% 37.82% 38.66% 38.1%
Total medical charge 29.22% 29.96% 31.07% 32.42% 31.12%
Table 4.4: Adjusted R-sq values from linear regression models using Dataset A. (Each value comes from
a significant model i.e. with a p-value below 0.0001.)
Outcome Indicator Null Charlson Elixhauser HCC red-HCC
Length of stay 41.17% 43.68% 47.62% 48.33% 46.23%
Total medical charge 34.35% 37.88% 40.23% 41.75% 39.14%
Total MBS fees 37.06% 40.94% 43.78% 45.72% 42.81%
Total medical benefit paid 35.30% 38.36% 41.21% 42.68% 39.93%
Total charge 38.22% 41.17% 43.39% 44.31% 42.68%
Table 4.5: Adjusted R-sq values from linear regression models using Dataset B. (Each value comes from
a significant model i.e. with a p-value below 0.0001.)
We can see from Tables 4.4 and 4.5 that the Null model performs the poorest overall. Elixhauser
model outperforms Charlson model overall. The HHS-HCC model outperforms every other classification
on every indicator and dataset. Our red-HCC model, sits between Charlson and Elixhauser models in
our aggregated version of Dataset B while it performs better than Elixhauser in Dataset A.
4.1.5 Clinical classification chosen and important remarks
In what follows, we work with our red-HCC classification. Our decision was based on our technological
constraints. To elaborate, later in this chapter we will introduce our concept of “neighbourhood of a
patient” which is then used to calculate the neighbourhood for every patient in Dataset A. This is done
before any analysis is performed. However, any preprocessing of the datasets provided (neighbourhood
finding for every patient falls in this category) had to be done using a local computer. This reduced
our processing power dramatically. Using the full version of the HHS-HCC, as we originally intended,
would have required a large amount of computational time under this constraint. Thus, we chose to work
with the smallest clinical classification that did not compromise explanatory power in our Orthopaedics
dataset: the red-HCC classification.
At a late stage in our research, we came across the Multipurpose Australian Comorbidity Scoring
System (MACSS). The MACSS has been developed and adapted for adjustment of comorbidity risk. ItMACSS
uses 102 comorbid conditions. Furthermore, it was recently adapted for the ICD10-AM [62]. This clinical
classification is not exhaustive. Given our Australian datasets, we wanted to compare its performance
with the HHS-HCC. Nonetheless, our technological constraints were still an unavoidable hurdle. Even if
the MACSS indeed performed better than the HHS-HCC, we would not have been able to use it due to
the computational time needed.
Going back to the red-HCC, for us to be able to use the step-by-step tables published by the CMS
[7], we developed a mapping between the ICD10-CM and the ICD10-AM. We were not able to have this
mapping validated by a clinical expert. In any case, our methodology for risk adjustment can be adapted
to any clinical classification we choose with no major changes required. This statement will be better
clarified in the next section.
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Finally, researchers have also considered binary outcome indicators, such as in-hospital mortality, for
assessing the performance of different clinical classifications [63, 64]. They do this by analysing different
logistic regression models. The reasons for not considering any of our binary outcome indicators for
assessing the performance of our clinical classifications follow.
i) Dataset B did not contain any binary indicators.
ii) The rate of occurrence of binary indicators in Dataset A was either below 16% or above 85%
(refer to Table 2.1). Thus, a random classifier will have an accuracy of at least 84% irrespective
of the outcome indicator and surgery type. Recall that the binary indicators are hospital acquired
complications flag, intensive care unit referral flag, re-operation flag, re-admission flag and overnight
flag.
4.2 Data representation
As mentioned in Section 2.1, we mainly considered the Orthopaedics dataset, Dataset A, as a case study
for our research. To this end, we need to represent our dataset in a very clear way. This will allow us to
explain our methodology in great detail.
We started by encoding every ICD10-AM code from our modified HCP data, Dataset B, using our red-
HCC clinical classification. Let us recall from the previous section that the red-HCC clinical classification
had in total 47 categories labelled MOD01 up to MOD25 and WHO01 up to WHO22. In this section we
added one binary flag: HCC flag (HCC stands for Hierarchical Condition Category). This binary flag
was calculated as the maximum of the binary flags MOD01 up to MOD25. In other words, if the patient
presented a HCC then its HCC flag will be 1, otherwise it will be 0. Thus, the red-HCC now has 48
categories in total.
Let D be the dataset generated by linking Dataset A with Dataset B. Specifically, we added to Dataset D
A the 48 binary categories related to the red-HCC clinical classification.
A patient admission, p, from our dataset D will have four main components
p= (pids,php,ps,po).
Now, we describe these components.
i) pids: surgery unique identifiers (IDs). This component stores four (ID)s: admission ID, patient ID,
surgeon ID and hospital ID. They are denoted by paid, ppid, psid and phid respectively.
ii) php: health profile of the patient. This component stores 51 values. These values relate to the
surgery performed on the patient, the age and gender of the patient and the 48 categories from the
red-HCC.
iii) ps: surgery related outcome indicators. This component stores the values of the 11 outcome
indicators (OI), OI.1 up to OI.11, from Section 3.1. Refer to Section 3.1 for full descriptions.
OI.1 - ps1: length of stay.
OI.2 - ps2: number of medical services billed by the principal surgeon, which is denoted by MBS
Items. MBS stands for Medicare Benefits Schedule.
OI.3 - ps3: medical out-of-pocket (OOP) amount from providers other than the principal surgeon,
denoted by Medical OOP not surgeon.
OI.4 - ps4: medical out-of-pocket amount from the principal surgeon, denoted by Medical OOP
surgeon.
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OI.5 - ps5: prostheses charge amount.
OI.6 - ps6: total charge amount.
OI.7 - ps7: Hospital Acquired Complications (HAC).
OI.8 - ps8: Intensive care unit (ICU).
OI.9 - ps9: Re-operation within 180 days, denoted by 180d Reop.
OI.10 - ps10: Readmission within 30 days, denoted by 30d Readmit.
OI.11 - ps11: Overnight flag.
iv) po: risk adjusted outlying behaviour. This component stores 11 binary values. Given an index i
between 1 and 11, poi equals to 1 if and only if there was enough evidence to suggest that the value
of psi was either an outlier or an unexpected flag. The evidence was compiled by considering the
health profile of the patient - the php component. Later in this chapter we will explain in greater
detail how this component was obtained.
The following is an example of a patient admission p ∈ D:
p=

51721920︸ ︷︷ ︸
paid
,19488754︸ ︷︷ ︸
ppid
,7821920︸ ︷︷ ︸
psid
,1288754︸ ︷︷ ︸
phid︸ ︷︷ ︸
pids - 4 values
, 8︸︷︷︸
surgery
, 28︸︷︷︸
age
, 0︸︷︷︸
gender
, 1︸︷︷︸
HCC flag
, 0, . . . ,1︸ ︷︷ ︸
MOD01 to MOD25
, 1, . . . ,0︸ ︷︷ ︸
WHO01 to WHO22︸ ︷︷ ︸
red-HCC - 48 values︸ ︷︷ ︸
php - 51 values
,
7︸︷︷︸
length of stay
,1,1990.75,2282.20,7690, 25254.55︸ ︷︷ ︸
total charge
,1,0,0,0,0
︸ ︷︷ ︸
ps - 11 values
,0,0,0,0,1,1,0,0,0,0,0︸ ︷︷ ︸
po - 11 values
 .
Remark: Changing the clinical classification will undoubtedly alter the dimension of the php component.
Nonetheless, once we choose a clinical classification, our methodology follows the same steps, irrespective
of how php was computed.
It is important for us to emphasise that the components pids, php and ps were either supplied or
developed before any comparisons and analysis were made, while the po component stored information
obtained after our risk adjustment methodology was applied.
4.3 Similarity and neighbourhood of patients
This section is central for our risk adjustment methodology. Let us recall that our broad definition of
risk adjustment follows that of [30]: “(...) the use of patient-level information to explain variation
in health care spending, resource utilisation and health outcomes over a fixed interval of time (...)”. In
this section, we propose a clear way to identify similar patients. This will allow comparisons at many
different levels that take into account a patient’s health profile.
In what follows, R denotes the set of real numbers, R+ denotes the set of non-negative real numbers
and R++ denotes the set of strictly positive real numbers. Given a set A and a natural number k (a
positive integer) the set Ak is defined as
Ak = {(a1, . . . ,ak) : ai ∈A for every i ∈ {1, . . . ,k}}.
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4.3.1 Similarity between patients
We used a weighted Euclidean distance, defined below, to measure the similarity between patients. weighted
Euclidean
distance
Consider two patients p, q ∈ D with p= (pids,php,ps,po), q = (qids, qhp, qs, qo) and health profiles php =
(php1 , · · · ,php51 ) and qhp = (qhp1 , · · · , qhp51 ), respectively.
Definition 4.1 Given a weight vector w ∈ R51++, the distance dw : D×D −→ R between patients p and
q is defined as
dw(p,q) :=
√√√√ 51∑
i=1
[
wi(phpi − qhpi )
]2
.
Remark: It is important to notice that the choice of the weight vector w and the distance dw are of
extreme importance. If there is evidence to suggest that certain conditions are more (or less) important
than others, it should be reflected with a high (or low) weighting factor. Also, if there is clinical evidence
suggesting that a combination of certain conditions (like diabetes and cancer) need to be weighted dif-
ferently, then we should consider a set of weights instead of a fixed one. Finally, clinical experts should
review the distance function and inform us how clinically meaningful it really is.
Having the distance dw defined and a patient admission p ∈ D, we can find the neighbourhood of neighbourhood
of a patientpatient p; that is, the group of patients which better resemble the patient p.
Definition 4.2 Given a patient admission p∈ D, a weight vector w ∈ R51++ and a small positive number
δ, we define the (δ,w)-neighbourhood of p as follows: (δ,w)-
neighbourhood
Nδ,w(p) := {q ∈ D : dw(q,p)< δ and q 6= p};
that is, the set of patients at distance less than δ from the patient p.
4.3.2 Neighbourhood finding methodology
In order to find a neighbourhood for each patient in our dataset, consider the following: let p ∈ D
S0. Choose two positive numbers δ0 and δMAX such that δ0 is smaller than δMAX and a weight vector
w0 ∈ R51++.
S1. Starting with δ = δ0 and w = w0, calculate Nδ,w(p).
S2. If the cardinality of Nδ,w(p) is below 10 (or empty), increase δ, adjust w and recalculate Nδ,w(p)
(the weight w needs to be adjusted to ensure that the range of the patient ages do not widen too
much).
S3. Repeat S2 until δ exceeds δMAX , or until the neighbourhood is (at least) of size 10.
S4. Denote the last Nδ,w(p) calculated as N (p).
Once N (p) has been found for every p ∈ D, different aggregation mechanisms can be employed in
order to compare healthcare providers and identify low performers.
Remark: We have not chosen a maximum number of neighbours since we did not want to impose
artificial boundaries or to arbitrarily remove “highly similar” neighbours. Regarding step S2, we have
not specified the update mechanism for δ and w. We believe that researchers should determine this
mechanism according to current datasets and clinical evidence.
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Setting up our neighbourhood finding methodology
In our analysis, the parameters δ0, δMAX and w0 where fixed as follows:
i) δ0 = 2;
ii) δMAX = 10; and
iii) w0 was given by
w0 =
M,aδ,M,M,2.25, 2, . . . ,2︸ ︷︷ ︸
46 times

where M = 100 and aδ = 0.75 for δ = δ0.
The value of M ensures that only patients undergoing the same surgery, of the same gender and who
have presented an HCC condition are compared.
S2 requires δ and w to be updated if the neighbourhood size is too small. Whenever needed, δ was
increased by 2 units. If δ was updated, the weight corresponding to the age parameter, aδ, was increased
by 0.75 units, thus ensuring that patients being compared are still of similar age. Current age weight
parameter ensured a difference of 3 years between the patient and his neighbours. Furthermore, notice
that, the lower the value of δ, the more “similar” the patients from the (δ,w)-neighbourhood are to the
patient p.
After every neighbourhood was found, we discarded any patient with a small (possibly empty) neigh-
bourhood. In total, 759 patients (out of 30,562) were discarded. More importantly, about 96% (out of
30,562) of our patients required a δ value lesser or equal than 6 for a neighbourhood to be found. The
remaining 4%, i.e. patients who could be misrepresented (discarded patients fall here), mostly underwent
surgeries corresponding to the lowest frequencies (hip revisions, knee revisions, shoulder arthroscopies,
shoulder replacements and shoulder revisions).
On the impact of the clinical classification and the weights chosen
If we were to update or use a completely different clinical classification for our patient health profile, we
will need to update the size of the weight vector w, its component values and the distance function dw
(which depends on w). This is the only variation in our neighbourhood finding methodology; in other
words, steps S0 to S4 would remain exactly the same, irrespective of the clinical classification.
In our initial weight vector chosen, namely w0, the last 47 entries are:
2.25, 2, . . . ,2︸ ︷︷ ︸
46 times
.
Recall that the last 47 entries of the current patient health profile, correspond to our red-HCC classifi-
cation. The weighs chosen imply that all these categories are equally important except the very first one
which was given a slightly higher importance. This category, if present, implies that the patient shows
disease interactions which affect costs highly, see Section 3.8 of [6].
The weights we chose were arbitrary. We could have used statistical models for finding a set of weights
that reflected best the differences between each category. However, we decided against that idea. Our
reasons follow.
i) We have more than one outcome indicator. Statistical models like the Cox proportional hazards
model, used by Charlson et al. [23] and Quan et al. [65], provide weights that are directly related
to only one outcome indicator.
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ii) Weights should be chosen by clinicians, since weights are related to clinical aspects of the patient
before any surgery is performed. This is important if we want to find similar patients. Once similar
patients are grouped together in a neighbourhood, variation in outcome indicators will reveal that
other factors outside the health profile of the patients inside the neighbourhood are at play. Clinical
opinion is therefore needed to assess the suitability of the weights chosen, the distance function
and the neighbourhoods found.
iii) Simplicity. Statistical models add complexity to the weigh selection process. As mentioned in Sec-
tion 1.1.2, private health insurance in Australia is highly political. By choosing a simple collection
of weights we aim at having a methodology which is accessible for a wide range of stakeholders,
policy makers and the public alike. The core principle of our methodology is that only similar
patients should be compared between themselves.
With our neighbourhood finding methodology clearly presented, we are ready to calculate the com-
ponent po, the risk adjusted outlying behaviour, for every patient admission p ∈ D.
4.4 Risk adjusted outlying behaviour (component po)
Now, we present how to determine if a given patient admission outcome indicator is an outlier or not.
Given a patient admission p ∈ D, the component po stored flags that represented if the variables
stored in the recorded surgery related outcome indicators, ps, were considered outliers, denoted as
OUT, or unexpected, denoted as UNEXP, given the patient health profile php. The value of poi , OUT
UNEXPwhere i ∈ {1, . . . ,11}, is 1 if the value of the outcome indicator i stored in psi is considered an outlier or
unexpected; 0 otherwise. Our concepts of “outlier” and “unexpected” are defined in this section.
Given p∈ D and his neighbours N (p), consider one of its surgery related outcome indicators psi , where
i ∈ {1, . . . ,11}. Also consider for each neighbour q in N (p) the same surgery related outcome indicator
qsi .
Set poi = 0. The value of poi is updated as follows.
OUT If psi represents the value of a continuous outcome indicator (e.g. length of stay, MBS items,
out-of-pocket from medical providers other than the principal surgeon, out-of-pocket from the
principal surgeon, prostheses amount charged and total amount charged), calculate the average x
and standard deviation σ of qsi for each neighbour q in N (p). Then determine how many standard
deviations away from the neighbours average psi is:
psi −x
σ
.
If this number is higher than 2 we flag that outcome indicator as an outlier by making poi = 1. outlier
UNEXP If psi represents the value of a binary outcome indicator (hospital acquired complication flag, inten-
sive care unit flag, re-operation flag, re-admission flag and overnight admission flag), calculate the
rate of occurrence among the neighbours, call it ri . If psi = 1 and the rate ri is below 50%, then
the outcome indicator was flagged as unexpected by making poi = 1. Otherwise, if psi = 0 and the unexpected
rate of the neighbour was above 50%, then the outcome indicator was flagged as unexpected by
making poi = 1.
Remark: We used two standard deviations above the neighbourhood average because, for all but
140 neighbourhoods (out of 30,562 neighbourhoods calculated), our data shows that at most 20% of
neighbours values are two standard deviations above of the mean of the neighbourhood.
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The next sections describe different aggregation mechanisms that are used for comparisons of providers.
For simplicity, we focus on aggregating at surgeon level only. Aggregation at hospital level can be done
just as easily.
4.5 Risk adjusted averages and personalised benchmarks
In this section we propose a method for calculating risk adjusted benchmarks and risk adjusted averages.
Given a surgeon ID, sid, let surg denote a particular surgery, Dsid,surg be the set of patients un-
dergoing surgery surg under surgeon sid, and let nsid,surg denote the number of patients of Dsid,surg.
Furthermore, let np be the number of patients of N (p) for any p ∈ D.
Let i∈ {1,2, . . . ,11} denote one of the 11 outcome indicators. The risk adjusted average of surgeonrisk adjusted
average sid for outcome indicator i of surgery surg, denoted RA-psi,surg,sid , is calculated by considering only
patients from Dsid,surg. Specifically, we compute the weighted average of the psi values of the patients
in Dsid,surg using np as weights. In other words, letting
Np :=
∑
p∈Dsid,surg
np,
we set
RA-psi,surg,sid :=
∑
p∈Dsid,surg
npp
s
i
Np
. (4.1)
Similarly, the risk adjusted benchmark of surgeon sid for outcome indicator i of surgery surg, denotedrisk adjusted
benchmark RA-Bsi,surg,sid , is calculated by considering only patients from Dsid,surg and calculating the weighted
average of the values psi , where psi is the average of qsi for every q in N (p). Letting
Np =
∑
p∈Dsid,surg
np,
we set
RA-Bsi,surg,sid :=
∑
p∈Dsid,surg
npp
s
i
Np
. (4.2)
Notice that if i corresponds to one of the binary outcome indicators, then psi becomes the proportion of
neighbours of p who had a value of one in outcome indicator i.
Remark: Notice that for every p ∈ D, the values of psi are calculated for every i ∈ {1,2, . . . ,11}. In
fact, in the next chapter, we will use these values for predictive purposes.
In an hypothetical example, consider a surgeon that has performed a knee replacement surgery to
two different patients, both 70 years old males who have not been in hospital in the 12 months prior to
the surgery. Furthermore, the ICD10-AM codes recorded in both separations are the same. Clearly, both
patients will have the same neighbourhood. Therefore, if we use Equations (4.1) and (4.2), we see that
the risk adjusted average of, say the length of stay, for this surgeon will be the simple average of both
patients’ length of stay. Similarly, the risk adjusted benchmark of the length of stay for this surgeon will
be the average of the neighbours’ length of stay.
Remark: Since the risk adjusted averages defined above depend greatly on the surgeon’s patient mix,
direct comparisons of these values between surgeons is absolutely discouraged.
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4.6 Risk adjusted relative frequency of outliers
Given a patient admission p ∈ D, the risk adjusted outlying behaviour component po defined in Sec-
tion 4.4 is aggregated at surgeon level. For each surgeon, we calculated the Relative Frequency of
Outliers/Unexpected occurrences (RFO in short) present for each surgery related outcome indicator. RFO
Given a surgeon ID, sid, let surg denote a particular surgery. Let Dsid,surg be the set of patients
undergoing surgery surg under surgeon sid. The number of patients of Dsid,surg is denoted by nsid,surg.
For every outcome indicator i ∈ {1, . . . ,11}, we define
RFOi,surg,sid :=
∑
p∈Dsid,surg
poi
nsid,surg
.
The number RFOi,surg,sid , represents what proportion of patients seen by surgeon sid undergoing surgery
surg had values in outcome indicator i that cannot be explained by the health profile of the patient alone.
Clearly, every surgeon had RFO values ranging between 0 and 1 for each outcome indicator and surgery
type.
The following section presents two different ranking of providers.
4.7 Comparative assessment of providers
In this section, we present two different ways to rank providers. On one hand, we use the risk adjusted
benchmarks and risk adjusted averages calculated in Section 4.5. On the other hand, we simply take
advantage of the risk adjusted Relative Frequency of Outliers (RFO) from Section 4.6.
4.7.1 Ranking of providers using risk adjusted benchmarks and averages
For any surgeon ID sid, and surgery type surg, we calculated risk adjusted averages RA-psi,surg,sid
and risk adjusted benchmarks RA-Bsi,surg,sid , for every outcome indicator i ∈ {1,2 . . . ,11} according to
Equations (4.1) and (4.2) respectively. Then, we calculated the following ratios
Ri,surg,sid :=
RA-psi,surg,sid
RA-Bsi,surg,sid
, for every i ∈ {1,2, . . . ,11}. (4.3)
For Surgeon sid performing surgery surg, the value of Ri,surg,sid represents, for outcome indicator i,
what percentage of his personalised benchmark the average is. We could state that whenever Ri,surg,sid
is below 1, provider sid has a high performance on outcome indicator i of surgery surg; while whenever
Ri,surg,sid is above 1 provider sid has a low performance on outcome indicator i of surgery surg.
Hence, we could also define
Rsurg,sid :=
11∑
i=1
Ri,surg,sid
and rank surgeons by surgery type by using Rsurg,sid from highest to lowest. A surgeon with a Rsurg,sid
that lies in the top 20% is identified with a low performance, while a surgeon with a Rsurg,sid that lies
in the bottom 20% is identified with a high performance.
Remark: Notice that, given an outcome indicator i ∈ {1, . . . ,11}, each surgeon could be ranked in-
stead by the value Ri,surg,sid only. By adding up all the Ri,surg,sid we are proposing a simple way to
consider the contribution of every outcome indicator at once. Also, notice that a low performing surgeon
on a given surgical procedure could be a high performing surgeon on another surgical procedure.
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4.7.2 Ranking by risk adjusted relative frequency of outliers
Recall from Section 4.6 that for any surgeon ID sid, surgery type surg, and outcome indicator i ∈
{1,2, . . . ,11}, the number RFOi,surg,sid , represents what proportion of patients seen by surgeon sid
undergoing surgery surg had values in outcome indicator i that cannot be explained by the health
profile of the patient alone.
For every surgeon, we calculate the sum of their RFO values by surgery type,
RFOsurg,sid :=
11∑
i=1
RFOi,surg,sid .
We call this value the RFO value of surgeon sid for surgery surg.
Finally, surgeons are ranked by the values of their RFO from highest to lowest per surgery type. A
surgeon with a sum of RFO values that lies in the top 20% is identified with a low performance, while
a surgeon with a sum of RFO values that lies in the bottom 20% is identified with a high performance
(similar ranking mechanism as in Section 4.7.1).
4.8 Summary
This chapter has presented in great detail our risk adjustment methodology. A high level summary of
each section follows.
Section 4.1 presented comparisons of different exhaustive clinical classification of ICD10-AM codes,
as well as our choice for defining the health profile of our patients. Recall that the health profile contains
diagnosis information 12 months prior to a patient admission.
Section 4.2 explained the encoding of our dataset at patient level. Our dataset included identifier
fields, health profile, outcome indicators and, at first, extra empty fields for each outcome indicator.
These empty fields were filled at a later stage.
Section 4.3 introduced our definitions of similarity between two patients and neighbourhood of a
patient. More importantly, we presented our neighbourhood finding methodology which needs to be
applied to each patient of our dataset.
Section 4.4 showed how to determine whether the outcome indicators of a patient were outliers or
not. For this, we required the neighbourhood of the patient. With this information, we populated the
empty fields initialised in Section 4.2. These fields form the risk adjusted outlying behaviour component.
The first four sections defined and analysed the patient health profile individually. Furthermore, we
compared outcome indicators of a patient against outcome indicators of patients from his neighbourhood.
The following sections described different aggregation mechanisms used for comparison of healthcare
providers. For simplicity, only surgeon level aggregations were presented. Nonetheless, hospital level
aggregations can be done just as easily.
Section 4.5 looked into risk adjusted averages and personalised benchmarks at provider level. From
Section 4.3, each patient had a neighbourhood associated to him. For every neighbourhood, we extracted
its size and the average values of every outcome indicator for the patients in the neighbourhood. This
information was used in the calculation of the risk adjusted averages and benchmarks.
Section 4.6 showed how the risk adjusted outlying behaviour component from Section 4.4 is aggregated
at provider level. This aggregation introduced the risk adjusted Relative Frequency of Outliers (RFO).
Section 4.7 presented two different ranking of providers. The first ranking took advantage of the risk
adjusted averages and benchmarks calculated in Section 4.5. The second ranking employed the sum of
RFOs as introduced in Section 4.6.
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We want to stress that any section starting from Section 4.2 is built with the results of previous
sections.
The next chapter proposes meaningful visualisations and the predictive capability of our methodol-
ogy.
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Chapter 5
Risk adjusted predictions and
visualisations of provider
comparisons
This chapter uses results and notations from Chapter 4. For the sake of readability, we reintroduce the
notations as needed. However, any detailed definitions or calculations can be found in the aforementioned
chapter.
This chapter assumes that every section from Chapter 4 is fully understood. Nonetheless, we highlight
which particular sections of Chapter 4 are relevant to sections of the current chapter.
We start this chapter by showing how our risk adjustment methodology can be used for predictions.
Afterwards, we perform several outcome indicator comparisons at surgeon and hospital levels. Unlike
Chapter 3, the comparisons we present in this chapter focus on a particular surgical procedure. No
consolidation mechanism is introduced. Although, a short discussion on how a consolidation could be
made is presented.
Our first visualisations are for the risk adjusted outlying behaviour of providers. This is accomplished
by using their Relative Frequency of Outliers (RFO in short). We present low performers and comparisons
between low and high performers at surgeon and hospital levels.
Afterwards, we present risk adjusted averages and personalised benchmarks at provider level. We
also show a way to rank providers by using this information.
5.1 Risk adjusted predictions at patient level
This section requires, as preliminary work, to follow the instructions from Sections 4.1, 4.2 and 4.3.
In summary, the following is assumed to be already done: definition of health profile; encoding of the
dataset at patient level; and, calculation of the neighbourhood of every patient in the dataset.
Recall from Section 4.2 that D denotes our dataset. Let us describe the following scenario: a patient
p /∈ D is admitted to hospital to undergo one of the ten surgeries of interest to us. In Section 4.5, it
was pointed out that we could use the neighbourhood of a patient for predictive purposes. This section
explains in detail how this is done and how good our predictions were in comparison to linear regression
models.
For Patient p, we can calculate its health profile php. In Section 4.2, we saw that the health profile
contains information about the surgery the patient is admitted for, his age, his gender and the diagnosis
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codes that have been captured prior to his admission to hospital, coded with our clinical classification of
choice.
Next, we find all the neighbours of p in our dataset D, using our neighbourhood finding methodology,
presented in Section 4.3.2. Recall that all we need to find the neighbours of p is his health profile. Let
N (p) be the set of all the neighbours of p found in D.
Hence, for every outcome indicator i ∈ {1,2, . . . ,11}, we expect that the outcome of patient p will be
equal to the expected value of its neighbours. For continuous outcome indicators, like length of stay, the
expected value is simply the average length of stay of every neighbour of p. For binary outcomes, like
referral to an Intensive Care Unit (ICU), the expected value is the proportion of his neighbours who had
an ICU. This proportion can be interpreted as the probability that Patient p will have an ICU.
To simulate this scenario several times and to test how accurate our predictions were, we used a
method called cross-validation [66]. By fixing one outcome indicator, say length of stay, we hold outcross-
validation 10% of our dataset D, this represented our validation set. For each patient from our validation set, we
validation set
look for their neighbours in the remaining 90% of our dataset, which represents our training set. Thentraining set
we calculated the Root Mean Squared Error (RMSE); see [66]:root mean
squared error
RMSE =
√√√√ 1
m
m∑
k=1
(yk− y˜k)2.
Here m is the number of patients in our validation set, yk is the length of stay of patient k and y˜k is its
predicted length of stay.
The RMSE is one of the most common measures used to quantify the extent to which the predicted
value for a given patient is close to the true value for that patient [66]. The RMSE will be small if the
predicted responses are very close to the true responses and will be large if, for some of the observations,
the predicted and true responses differ substantially.
To know how small our RMSE was, we compared it against the error obtained by running a linear
regression model on our validation and training sets. We used the same patient health profile of our
training set to find the line that best fitted the length of stay. We then used this line to predict the
length of stay of every patient from the validation set. Thus, we calculated the RMSE of this regression
model.
Since the RMSE values can be quite sensitive to our training and validation sets, we repeated this
entire process ten times and compared the average RMSE calculated from our predictions against the
average RMSE calculated from the linear regression model.
Remark: In the literature [66], besides the RMSE, other measures to quantify prediction error ex-
ist. We settled in working only with the RMSE mostly because linear regression models are designed to
minimise this quantity (see Appendix B). Thus, we wanted to know how badly this error became once
we introduced our neighbourhood concept.
The following summarises the explanation above. Let i represent a continuous outcome indicator.
i) Randomly split dataset D into validation and training sets. The validation set is made out of 10%
of the dataset and the rest is the training set.
ii) For every patient in the validation set, find neighbours from the training set. The risk adjusted
prediction of i for patient p is given by the average value of i of all his neighbours. Calculate the
RMSE and denote it by RMSEra.
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iii) Use the training set to find the line that best fit i by using patient health profiles as inputs. For
every patient in the validation set, his prediction is obtained by calculating the value predicted by
the line found with the training set. Calculate the RMSE and denote it by RMSEl.
iv) Repeat steps i) to iii) ten times and calculate the average of the ten values of RMSEra and the ten
values of RMSEl. Denote these averages by RMSErai and RMSEli, respectively.
v) Calculate
R= RMSE
ra
i
RMSEli
.
Notice that if R is below 1, then our predictions were better than the linear regression model. Table 5.1
presents our results.
Remark: We considered only continuous outcome indicators in our cross-validation experiments. Re-
call from Table 2.1 that the rate of occurrence of binary indicators was either below 16% or above 85%.
Thus, a random classifier will have an accuracy of at least 84% irrespective of the outcome indicator and
surgery type.
Outcome Indicator (i) RMSEli RMSErai R
Length of stay 3.329 3.777 1.135
MBS items 0.956 0.977 1.021
Medical OOP not from surgeon 345.15 352.57 1.021
Medical OOP from surgeon 863.07 882.17 1.022
Prostheses charge 1887.76 1935.18 1.025
Total charge 3831.39 4273.17 1.112
Table 5.1: Comparing prediction errors between our risk adjustment methodology and linear regression
models.
Each line From Table 5.1 highlights the results obtained after applying steps i) to v) for every out-
come indicator listed. As an example, consider length of stay. The dataset D was split into validation
and training sets and the RMSEra and RMSEl values were calculated. This process was repeated for a
total of ten times and every RMSEra and RMSEl values were stored. On one hand, the RMSEli value of
3.329 is the average of the ten RMSEl stored values. On the other hand, the RMSErai value of 3.777 is
the average of the ten RMSEra stored values. Finally, the R value of 1.135 was calculated after dividing
RMSErai by RMSEli.
Remark: The fact that every RMSEli is smaller than the corresponding RMSErai is not surprising.
Recall linear regression models were built by minimising the RMSE. Nonetheless, the R values show that
the RMSErai values are higher by as little as 2% and as high as 13% of the corresponding RMSEli value.
Our risk adjustment methodology was designed while keeping in mind our desire for finding one
approach that could compare the performance of healthcare providers, regardless of outcome indicator,
procedure, patient or place of care. The result was a methodology with two important qualities: simplicity
and clarity. These two qualities made our methodology approachable. In other words, our methodology
can be scrutinised by different actors of the Australian healthcare system (e.g.: patients, doctors, policy
makers, analysts, etc.). Table 5.1 tells us that this transparency comes at a price when compared to
linear regression models: a slightly higher RMSE. We believe this to be a very small price to pay.
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5.2 Risk adjusted relative frequency of outliers
This section requires the same preliminary work as Section 5.1 and to follow the instructions from
Sections 4.4, 4.6 and 4.7.2. In summary, the following is assumed to be already done: definition of health
profile, encoding of the dataset at patient level, calculation of the neighbourhood of every patient in the
dataset, calculation of the risk adjusted outlying behaviour component, its aggregation at provider level
and the ranking mechanism defined with it.
In particular, Section 4.6 defined the number RFOi,surg,sid , which represents what proportion of
patients seen by surgeon sid undergoing surgery surg had values in outcome indicator i∈ {1, . . . ,11} that
cannot be explained by considering the health profile of the patient only. By definition, RFOi,surg,sid is
a numerical value between 0 and 1 inclusive.
5.2.1 Surgeon level risk adjusted comparisons
Fixing i and surg we plotted a boxplot of the RFOi,surg,sid values for every surgeon. Let us denote by
Q1, Q2, Q3 and IQR by the 1st, 2nd, 3rd Quartile and the Interquartile Range, respectively. Figure 5.1IQR
shows side-by-side boxplots of every outcome indicator for surgeons performing knee arthroscopies. We
only considered surgeons performing at least five surgeries (1,845 surgeons out of 3,470 surgeons were
discarded). We have also highlighted the RFO values of a particular surgeon who was involved in more
than 40 separations (values plotted with stars). We colour coded surgeon’s RFO values in the following
way:
i) RFO was coloured GREEN if RFO < Q1−1.5·IQR.
ii) RFO was coloured LIGHT GREEN if Q1 −1.5·IQR ≤ RFO < Q1.
iii) RFO was coloured YELLOW if Q1 ≤ RFO < Q3.
iv) RFO was coloured ORANGE if Q3 ≤ RFO < Q3−1.5·IQR.
v) RFO was coloured RED if RFO ≥ Q3+1.5·IQR.
As a simple rule, we can consider any values below Q1 to be “good” and any values above Q3 to be
“bad”. The colour scheme chosen takes this into account: we use the colour green for the “best” values
which are those considerably lower than Q1, and the colour red for the “worst” values which are those
considerably higher than Q3.
Notice in Figure 5.1 that we are depicting the RFO of every outcome indicator, however we are using
the same terminology for each outcome indicator as in Chapter 3. Furthermore, we have added three
additional boxplots that help us assess quickly the overall patient characteristics that this surgeon has
seen. The three variables we included were HCC Ratio, Delta and Member Age.
i) HCC Ratio: rate of patients presenting a Hierarchical Condition Category (HCC) flag, refer to
Sections 4.1 and 4.2 for definition and calculation of the HCC flag. Recall that a patient presenting
an HCC is expected to cost more in the American context (Section 1.4.3).
ii) Delta: this is the average of the δ parameter used in our neighbourhood finding algorithm, divided
by 10. Recall from Section 4.3.2 that δ ∈ {2,4,6,8,10} thus, by dividing the average value of δ
by 10 we have a value between 0 and 1. The smaller value of δ, the closer the patients in the
neighbourhood are to our patient of interest.
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Figure 5.1: Risk Adjusted RFO across outcome indicators. Example of a low performing surgeon for
knee arthroscopy with more than 40 separations. Numbers represent the values of the corresponding
outcome indicator for the surgeon (plotted with stars).
iii) Member Age: this is in fact the RFO for the variable Member Age. Since we have already included
this variable in our neighbourhood finding methodology, we expect it to be always close to zero.
Otherwise, our neighbourhood quality might be put into question (low neighbourhood sizes in other
surgeries make this parameter relatively far from zero).
Figure 5.1 shows a surgeon, who after performing more than 40 knee arthroscopies in 2014, seems
to have high relative frequency of outliers for length of stay (31.4%), out-of-pocket amounts charged by
medical providers other than the principal surgeon (38.8%) and overnight admissions (50%).
A knee arthroscopy is usually a same day procedure [45, 46]. According to the neighbours of the
patients seen by the surgeon of our example, there was a probability of at most 20% for his patients to
be admitted for more than one day. If we look at the boxplots related to the patient characteristics, his
patients do not seem to have presented high cost conditions (evidenced by the low HCC ratio, 5.5%) and
the neighbours of his patients seem to be quite close (as evidenced by his low average Delta, 2.48). At
this point a valid question that will remain unanswered is: which factors not considered in our model
could explain the high out-of-pocket amounts charged and the high rate of overnight admissions for this
surgeon?
Surgeon performance before and after risk adjustment
As presented in Section 4.7.2, surgeons are ranked by the sum of their RFO values by surgery type. A
surgeon with a sum of RFO values that lies in the top 20% is identified with a low performance, while a
surgeon with a sum of RFO values that lies in the bottom 20% is identified with a high performance.
In Section 3.3.1, we ranked providers in a different way. It was a ranking that did not take into
account any form of risk adjustment. Let S be a surgeon who was found to be a low performing surgeon
for knee arthroscopy under this ranking. Figure 5.2 presents the scorecard of Surgeon S, this scorecard
does not include risk adjustment. Figure 5.3 represents the risk adjusted RFOs of Surgeon S.
Figure 5.2 shows that this surgeon’s out-of-pocket amounts seem to be driving his low performance.
After risk adjustment and according to the ranking from Section 4.7.2, we found this surgeon among the
high performing group. Nonetheless, Figure 5.3 shows that the only outcome indicator that had a high
RFO was the out-of-pocket amount charged by the surgeon. The fact that the RFO for out-of-pocket
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Figure 5.2: Scorecard of surgeon S for knee arthroscopy with more than 30 separations without risk
adjustment.
Figure 5.3: Risk Adjusted RFO across outcome indicators for knee arthroscopy of Surgeon S with more
than 30 separations.
amount for medical providers other than the principal surgeon and the total charge are low suggest that
the high costs highlighted in the unadjusted scorecard can be explained by his patients’ health profile.
Comparing two surgeons after risk adjustment
After ranking surgeons according to the ranking from Section 4.7.2, Figure 5.4 compares a low performing
surgeon (plotted with red stars joined by red segments) with a high performing surgeon (plotted with
blue stars joined by blue segments).
We can see in Figure 5.4 that the high performing surgeon has RFO values of 0 for our outcome indi-
cators while the low performing surgeon has very high RFO values for out-of-pocket amounts, prostheses
charge, total charge, overnight admissions and length of stay. Notice that the low performing surgeon
has an HCC ratio equal to 0, with an average Delta value of 3.12. Therefore, the variation in costs and
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Figure 5.4: Risk Adjusted RFO across outcome indicators. Example of low and high performing surgeons
for knee arthroscopy. Numbers in bottom row represent the values of the high performing surgeon (plotted
with blue stars) while the numbers above the bottom row are the values of the low performing surgeon
(plotted with red stars). Low performing surgeon had less than 20 separations. High performing surgeon
had more than 30 separations.
length of stay cannot be explained with by his patients’ health profile alone.
5.2.2 Hospital level risk adjusted comparisons
We will now present our comparisons at hospital level. Like before, we will present the risk adjusted
RFO at hospital level for knee arthroscopy. Figure 5.5 shows side-by-side boxplots for every outcome
indicator for hospitals performing knee arthroscopies. We only considered hospitals performing at least
20 surgeries (787 hospitals out of 1167 hospitals were not considered).
As presented in Section 4.7.2, hospitals are ranked by the sum of their RFO values by surgery type.
A hospital with a sum of RFO values that lies in the top 20% is identified with a low performance, while
a hospital with a sum of RFO values that lies in the bottom 20% is identified with a high performance.
Figure 5.5 shows a hospital which after performing more than 120 knee arthroscopies in 2014 and
in comparison to other hospitals, seems to have high relative frequency of outliers (RFO) for length of
stay (20.2%), total charge (13.8%) and overnight admissions (32.4%). Notice that, in this example, even
though the RFO related to member age seems to be problematic, a closer inspection shows that the
neighbours are actually of good size and with a relatively low Delta value (average of 2.54).
Comparing two hospitals after risk adjustment
After ranking hospitals according to the ranking from Section 4.7.2, Figure 5.6 compares a low performing
hospital (plotted with red stars joined by red segments) with a high performing hospital (plotted with
blue stars joined by blue segments).
We can see in Figure 5.4 that the high performing hospital has RFO values close to 0 for our outcome
indicators, while the low performing hospital has very high RFOs for out-of-pocket amounts, prostheses
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Figure 5.5: Risk Adjusted RFO across outcome indicators. Example of a low performing hospital for
knee arthroscopy with more than 120 separations. Numbers represent the values of the hospital (plotted
with stars).
Figure 5.6: Risk Adjusted RFO across outcome indicators. Example of low and high performing hospitals
for knee arthroscopy. Numbers in bottom row represent the values of the high performing hospital
(plotted with blue stars) while the numbers above the bottom row are the values of the low performing
hospital (plotted with red stars). Low performing hospital had less than 100 separations. High performing
hospital had more than 120 separations.
charge, total charge, overnight admissions and length of stay. Notice that both hospitals have similar
HCC ratios (around 8%) and their average Delta value are actually not that different (2.4 for high
performing hospital and 3.06 for low performing hospital). Therefore, the variation in costs and length
of stay cannot be explained by its patients’ health profile alone.
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5.3 Risk adjusted outcome indicators and personalised bench-
marks
This section requires the same preliminary work as Section 5.1 and to follow the instructions from
Sections 4.5 and 4.7.2. In summary, the following is assumed to be already done: definition of health
profile, encoding of the dataset at patient level, calculation of the neighbourhood of every patient in
the dataset, calculation of risk adjusted averages and benchmarks at provider level, and the ranking
mechanism defined with them.
In particular, Section 4.5 explained how to calculate risk adjusted benchmarks and risk adjusted
averages at surgeon level of our outcome indicators per surgery type. We also showed how using the
ratio of these risk adjusted values (risk adjusted average divided by risk adjusted benchmark) can allow
us to rank our providers. We denoted this ratio by Ri,surg,sid , where sid was a surgeon ID from our
dataset D, surg was a surgery type and i ∈ {1, . . . ,11} was an outcome indicator; see Equation (4.3).
The value of Ri,surg,sid is always a positive number. A value of 1 means that the average of the risk
adjusted outcome indicator is equal to the risk adjusted benchmark.
5.3.1 Surgeon level risk adjusted averages, benchmarks and comparisons
Fixing i and surg we plotted a boxplot of Ri,surg,sid for every surgeon who has performed at least five
separations. Figure 5.7 shows side-by-side boxplots for every outcome indicator for surgeons performing
knee arthroscopies.
Figure 5.7: Ratio of risk adjusted averages and benchmarks. Example of a surgeon for knee arthroscopy
with more than 40 separations. Numbers in bottom row represent the personalised risk adjusted bench-
marks of the surgeon plotted with stars. Numbers next to plotted stars are the risk adjusted values of
the surgeon. If the ratio of any outcome indicator is equal to 1, it will be plotted on top of the horizontal
dashed line.
Figure 5.7 shows a surgeon who after performing more than 40 knee arthroscopies in 2014 and in
comparison to his peers, has ratios considerably larger than his peers for the out-of-pocket amount of
medical providers other than himself and the overnight admission rate.
Remark: Ratio values above 10 were changed to 10. This was to avoid that really large ratio val-
ues have a huge impact on the ranking of providers. Also, there were two variables that required further
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adjustment, the ratios corresponding to the rates of Hospital Acquired Complications (HACs) and In-
tensive Care Unit transfer (ICUs). The risk adjusted benchmarks were close or equal to 0. Therefore,
the calculation of these ratios were either really large values (when the benchmark was extremely small)
or not possible altogether (when the benchmark was 0). For these variables we considered the following
rules:
i) If the risk adjusted average was equal to the risk adjusted benchmark, we made the ratio equal to
1, regardless of whether or not the risk adjusted benchmark was 0.
ii) If the risk adjusted benchmark was 0 but the risk adjusted average was not, then we made the
ratio equal to 5. In this way, we controlled the effect of this particular parameter on the ranking
of providers.
After risk adjustment, for the surgeon depicted in Figure 5.7, we expected that medical providers
other than him charged on average AU$ 74. In reality, they charged more than 4 times that figure
(AU$ 309). We also expected that no more than 9.45% of the separations performed by this surgeon
were overnight admissions; in reality 50% of his separations were overnight admissions. Regarding ICU
transfers, we expected none of his patients to be in ICU; in reality 0.28% of his patients were indeed
transferred to ICU. These discrepancies cannot be explained by his patient’s health profile alone.
Comparing two surgeons after risk adjustment
We will use the ranking mechanism presented in Section 4.7.1.
Surgeons are ranked by surgery type by means of Rsurg,sid , where
Rsurg,sid =
11∑
i=1
Ri,surg,sid .
A surgeon sid with a value of Rsurg,sid that lies in the top 20% is identified with a low performance for
surgery surg, while a surgeon with a value of Rsurg,sid that lies in the bottom 20% is identified with a
high performance for surgery surg.
Figure 5.8 compares a low performing surgeon (plotted with red stars joined by red segments) with
a high performing surgeon (plotted with blue stars joined by blue segments). We can see in Figure
5.8 that the high performing surgeon has risk adjusted values well below his personalised risk adjusted
benchmark, while the low performing surgeon has risk adjusted values well above his personalised risk
adjusted benchmarks. Notice that the personalised benchmarks are very similar between these two
surgeons. The discrepancies in their ratios cannot be explained by the patients’ health profile alone.
5.3.2 Hospital level risk adjusted indicators, benchmarks and comparisons
We will present now our comparisons at hospital level. As before, we will present the ratio of the
risk adjusted average divided by the risk adjusted personalised benchmark at hospital level for knee
arthroscopy. Figure 5.9 shows side-by-side boxplots for every outcome indicator for hospitals performing
knee arthroscopies. For plotting the boxplots, we only considered hospitals performing at least 20
separations.
Figure 5.9 shows a hospital that, after performing more than 100 knee arthroscopies in 2014 and in
comparison to other hospitals, seems to have a high ratio of out-of-pocket amounts, prostheses charge
and overnight admissions. After risk adjustment, we expected this hospital to have a rate of 9.77% of
overnight admissions; in reality it has a rate of 31.42%. In out-of-pocket amount for medical providers
other than the principal surgeon, we expected AU$ 78; in fact, this hospital charges on average AU$ 260.
These discrepancies cannot be explained by its patients’ health profile alone.
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Figure 5.8: Ratio of risk adjusted outcome indicators and benchmarks. Example of low and high per-
forming surgeons for knee arthroscopy. Numbers in bottom row represent the personalised risk adjusted
benchmarks of the high performing surgeon (plotted with blue stars) while the numbers above the bot-
tom row are the risk adjusted benchmarks of the low performing surgeon (plotted with red stars). If the
ratio of any outcome indicator is equal to 1, it will be plotted on top of the horizontal dashed line. Low
performing surgeon had less than 20 separations. High performing surgeon had more than 50 separations.
Figure 5.9: Ratio of risk adjusted outcome indicators and benchmarks. Example of a hospital for
knee arthroscopy with more than 100 separations. Numbers represent the personalised risk adjusted
benchmarks of the hospital plotted with stars. If the ratio of any outcome indicator is equal to 1, it will
be plotted on top of the horizontal dashed line.
Comparing two hospitals after risk adjustment
We will use the ranking presented in Section 4.7.1.
Hospitals are ranked by surgery type by means of Rsurg,hid ,
Rsurg,hid =
11∑
i=1
Ri,surg,hid .
67
A hospital hid with a value of Rsurg,hid that lies in the top 20% is identified with a low performance for
surgery surg, while a hospital with a value of Rsurg,hid that lies in the botoom 20% is identified with a
high performance for surgery surg.
Figure 5.10 compares a low performing hospital (plotted with red stars joined by red segments) with
a high performing hospital (plotted with blue stars joined by blue segments).
Figure 5.10: Ratio of risk adjusted outcome indicators and benchmarks. Example of low and high
performing hospitals for knee arthroscopy. Numbers in bottom row represent the personalised risk
adjusted benchmarks of the high performing hospital (plotted with blue stars) while the numbers above
the bottom row are the values of the low performing hospital (plotted with red stars). If the ratio of any
outcome indicator is equal to 1, it will be plotted on top of the horizontal dashed line. Low performing
hospital had less than 100 separations. High performing hospital had more than 100 separations.
We can see in Figure 5.10 that the high performing hospital has risk adjusted values well below
its personalised risk adjusted benchmark, while the low performing hospital has risk adjusted values
well above its personalised risk adjusted benchmarks. Notice that the personalised benchmarks are very
similar between these two hospitals. The discrepancies in their ratios cannot be explained by the patients’
health profile alone.
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Concluding remarks and open
questions
Our main research question was the following: is it true that in Australia the more we pay, the higher
quality healthcare we get?
As our research evolved, we were also interested in answering the following questions:
i) For cost, what is a benchmark we should compare a patient against? Can we find benchmarks for
other outcome indicators?
ii) Can we develop a risk adjustment methodology that is consistent across different outcome indica-
tors?
After analysing the datasets provided by one of the largest Private Health Insurers in Australia, this
thesis is able to conclude that in Australia we are not always paying more for higher quality healthcare.
After taking into account different outcome indicators and patient characteristics, we can point out
healthcare providers which should be investigated further to understand other possible factors, not
included in our model, which can be responsible for large variations in their costs.
Comparisons should always take into account patient characteristics whenever possible. To this end,
we developed a risk adjustment methodology that is flexible. Our methodology is flexible since we
can update/change two main components as new evidence might suggest or as required by different
stakeholders: the patient health profile and the distance (or similarity) between patients.
In fact, depending of the data that can be accessed by different policy makers and analysts, we
proposed different comparison mechanisms that can be used at different levels, namely, patient, principal
surgeon and hospital. These comparison mechanisms include unadjusted and risk adjusted comparisons.
Regarding benchmark information in unadjusted comparisons, for continuous outcome indicators
(e.g.: costs and length of stay) we chose the median value of our population as our benchmark. For
binary indicators like presentation to intensive care unit, we looked at the rate of occurrence in our
population as an expected probability of occurrence. To condense meaningful information regarding
benchmarks and performance in one single graph, we used radar plots (Chapter 3). Even though other
researchers have found evidence of lack of understanding for this type of visualisations, we strongly
believe that healthcare professionals could benefit from familiarising with them.
Usual approaches of risk adjustment rely on regression models. These models target a specific outcome
indicator. In contrast, our risk adjustment methodology is able to compare healthcare providers across
different outcome indicators and procedures. Given a patient health profile, we find patients with similar
health profiles before any information regarding outcome indicators is processed. Thus, the similarity of
our patients is unaffected by the values of the outcome indicators. In particular, we were able to explain
some of the high costs associated to some patient admissions. However, there were also many other cases
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in which our patient health profile could not explain such high costs. In the future, we will look for other
factors that can be added to our model.
It is our firm belief that our approach can tackle one important aspect of the current Australian
healthcare system that urgently needs improvement: performance information sharing. Our methodology
was designed to be clear and scrutinised by different actors of the healthcare system (e.g.: patients,
doctors, policy makers, administrators, etc.).
To conclude, we would like to leave some open questions that will motivate our future research.
i) Are the choices of our distance between patients function and the weight vector, presented in
Section 4.3, clinically meaningful?
ii) Is it possible to include Pharmaceutical and General Practitioner data in a patient’s health profile?
iii) It is understood that some doctors work at different practises and/or hospitals. Are patient out-
comes and costs affected by the doctor’s team or place of practise?
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Appendix A
The six aims for the healthcare
system
The Institute of Medicine (IOM) in 2001 published a book that made an urgent call for fundamental
change to close the quality gap in the American healthcare system [67]. To enable this fundamental
change, the Institute highlighted six specific aims for improvement that could rise the quality of care to
unprecedented levels.
The IOM focused specifically on the improvement of healthcare services to individuals. Therefore, the
IOM described the six aims for improvement from the perspective of the individual’s experience. Even six aims
though the IOM introduced their six aims 16 years ago, they still remain valid in our current context.
The six aims are the following:
A1 Safety.
A2 Effectiveness.
A3 Patient-Centred.
A4 Timeliness.
A5 Efficiency.
A6 Equity.
The following subsections provide a small description of each of the aims.
A.1 Safety
Patients should not be harmed by the medical providers that are intended to help them, nor should
medical providers be harmed.
An earlier report by the IOM defined patient safety as freedom from accidental injury (see [67] and patient safety
references therein). Although not all errors cause injury, accidental injury can be due to error. An error error
is defined by the IOM as either
i) the failure to complete as intended a planned action, or
ii) the use of a wrong plan to achieve an aim.
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For example, in healthcare these errors include administering the wrong drug or dosage to a patient,
diagnosing pneumonia when the patient has congestive heart failure, and failing to operate when obvious
signs of appendicitis are present. Processes should be designed while considering patients’ well-being:
avoiding exposing patients to chemicals, foreign bodies, trauma or infectious agents.
The healthcare environment should be safe for all patients, in all of its processes, all the time.
Specifically, in a safe system information is not lost, inaccessible, or forgotten in transitions. Knowledge
about patients is available, with appropriate assurances of confidentiality, to all who need to know it,
regardless of where and when they become involved in the process of providing care.
Ensuring patient safety also requires that patients be informed and participate as fully as they wish
and are able.
A.2 Effectiveness
To say that a healthcare intervention is effective, implies an evidence-based practise. Evidence-basedeffective
evidence-based
practise
practise is the integration of best research evidence with clinical expertise and patient values.
We need to be aware that for many areas of healthcare, little or no evidence of either effectiveness
or ineffectiveness exists. In other areas, evidence may be available only for certain patient groups or for
patients who do not have coexisting health problems. Thus, it is clearly not possible to base all care on
sound scientific evidence.
Knowing which services are likely to be effective also requires that healthcare systems continuously
monitor the results of the care they provide and use that information to improve care for all patients. At
the very least, healthcare practitioners and organisations must be reflective and systematic in studying
their own patterns of care and outcomes.
A.3 Patient-centred
This aim focuses on a patient’s experience of illness and healthcare and on the systems that did or did
not work in meeting individual patient’s needs.
Patients and their families are now better educated and informed about their healthcare than ever
before. This represents a new opportunity for responding to patient needs and re-establishing clinical-
patient relationships. The right of patients to be informed decision makers is well accepted, however this
right is not always well implemented.
Healthcare should cure whenever possible but must always help to relieve suffering. To accomplish
these goals, technical care and interpersonal interactions should be customised to meet the needs and
preferences of individual patients.
Patients differ in their views about how active they wish to be in decision making. In some cases,
patients want a large role and in other cases they may delegate most decision making to a clinician.
A.4 Timeliness
Timeliness is an important characteristic of any service and is a legitimate and valued focus of improve-
ment in healthcare and other industries. In addition to stress, physical harm may result, for example,
from a delay in diagnosis or treatment that results in preventable complications. Lack of timeliness also
signals a lack of attention to flow and a lack of respect for the patient that must not be tolerated in
consumer-centred systems. It suggests that care has not been designed with the welfare of the patient
at the centre.
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Waits also affect medical providers. Some surgeons can’t start a surgery on time; doctors and nurses
wait “on hold” as they try to track down vital information; and delays and barriers involved in referrals
consume the time and energy of both referring doctors and consulting specialists.
Any high-quality process should flow smoothly. Delays should occur rarely. Waiting times should be
continually reduced for both patients and medical providers. Much waiting today appears to result from
the presumption that face-to-face encounters are required for patients to receive the help or treatment
they require. Health systems must develop multiple ways of responding to patients’ needs beyond patient
visits, including the use of the Internet.
A.5 Efficiency
In an efficient healthcare system, resources are used to get the best value for money. The opposite efficient health-
care systemof efficiency is waste, often exemplified by the use of resources without benefit to the patients. There are
at least two ways to improve efficiency:
i) reduce quality waste, and
ii) reduce administrative or production costs.
Not all but many types of quality improvements result in lower resource use. This is true for im-
provements in effectiveness that result from reductions in overuse. It is also true for most improvements
in safety which result in fewer injuries.
Waste can also be reduced by recycling, reusing and substituting wisely resources such as data and
water. Other approaches rely on matching supply to demand and using sampling for measurement
instead of measuring 100 percent of events.
A.6 Equity
This aim has two dimensions: equity at the level of the population and equity at the level of the individual.
At the population level, the goal of a healthcare system is to improve health status in a manner that
reduces health disparities among particular subgroups. Equity in care implies universal access. equity
All individuals expect to be treated fairly by healthcare organisations. The availability of care and
quality of services should be based on individuals’ particular needs and not on personal characteristics
unrelated to the patient’s condition or their reason for seeking care. In particular, the quality of care
should not differ because of gender, race, age, ethnicity, income, education, disability, sexual orientation
or location of residence.
A.7 Conflicts among the aims
For the most part, the six aims are complementary and synergistic. At times, however, there will be
tensions among them. Healthcare institutions, clinicians and patients will sometimes work together to
balance competing or conflicting objectives. A clear example is the potential conflict between patient-
centred and effectiveness.
The IOM emphasised that the commitment to patient-centred care is not intended to imply that
clinicians have an obligation to provide unnecessary services merely because patients request them. All
unnecessary services have the potential to cause harm. For example, false-positive results on a test can
lead to a cascade of testing and psychological distress. If certain treatment is of no benefit to the patient,
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ethical principles compel any physician to not recommend it or prescribe it, even if the patient requests
it.
74
Appendix B
Linear regression models: an
overview
This appendix gives an overview of linear regression models; for a more comprehensive description, refer
to [66].
In general, the goal of regression models is to use a set of variables X to measure or explain what
influence they have on another set of variables Y. The variables X are called as inputs while the
variables Y are called as outputs. In particular, a linear regression model assumes that the output input and out-
put variablescan be best approximated by a linear combination of the inputs. Its simplicity makes it a very popular
regression model.
In regression models, the Y variables are quantitative variables while the X variables can be either
quantitative or qualitative varibles. Qualitative variables take on values in one of many different classes quantitative
and qualitative
variables
or categories. Examples include person’s gender (male or female), the brand of product purchased (brand
A, B, or C), or a cancer diagnosis (Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, or No
Leukemia). In contrast, quantitative variables take on numerical values. Examples include a person’s
age and height.
Denote by RN the set (r1, . . . , rN ) with ri ∈ R; and by RN×p the set of matrices with N rows and p
columns whose entries are all real numbers.
In this section, Y = (y1, . . . ,yN ) ∈ RN and X ∈ RN×p. The N rows of X are denoted by x1, . . . ,xN .
A single element located in row i ∈ {1, . . . ,N} and column j ∈ {1, . . . ,p} is denoted by xij .
In a linear regression model, typically, we have a set of training data (x1,y1), . . . ,(xN ,yN ) from which
to estimate the parameter vector β = (β0, . . . ,βp) that minimise the residual sum of squares (RSS): residual sum of
squares
RSS =
N∑
i=1
yi−β0− p∑
j=1
xijβj
2 .
Once the parameter vector β is found, for a given input Xˆ = (xˆ1, . . . , xˆp), our regression model
estimates a value for our output variable, yˆ, as
yˆ = β0 +
p∑
j=1
xˆjβj .
Recall that the Root Mean Squared Error (RMSE) was defined in Section 5.1 as follows
RMSE =
√√√√ 1
N
N∑
k=1
(yk− yˆk)2.
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Thus, we can see that
RMSE =
√
1
N
RSS.
Therefore, in linear regression, minimising RSS is equivalent to minimising RMSE.
The parameter β0 is the intercept term, that is, the expected value of yˆ when Xˆ is equal to the zerointercept
vector. And βj represents the average increase in yˆ associated with one unit increase in xˆj .
Figure B.1: Example of a linear regression model.
In Figure B.1, the residual εi is defined by εi = yi−β0−xiβ1. Thus, the RSS can also be definedresidual
by
RSS =
N∑
i=1
ε2i .
Let
y = 1
N
N∑
i=i
yi
and define the total sum of squares, TSS, bytotal sum of
squares
TSS =
N∑
i=1
(yi−y).
Then, the R-sq statistic is calculated as follows:R-sq
R-sq = 1− RSSTSS .
The R-sq provides a measure of the linear fit. The R-sq statistic measures the proportion of variability
in Y that can be explained using X. To notice, it is possible to obtain a negative R-sq. This just means
that the fit is actually worse than just fitting a horizontal line.
In Section 4.1.3, we compared several linear regression models. We used different inputs for the same
output. Since the inputs contained different number of variables the R-sq statistic was not suitable for
comparisons. Notice that, in the definition of the R-sq statistic, the RSS (residual sum of squares) always
decreases as more variables are added to the model. Instead, the adjusted R-sq statistic was used. Foradj R-sq
a linear regression model with d variables, the adj R-sq statistic is calculated as follows:
adj R-sq = 1− RSS/(N −d−1)
TSS/(N −1) .
Notice that, by adding unnecessary variables to the model, the value of d will increase, this will lead to
an increase in RSSn−d−1 and consequently a decrease in the adj R-sq.
Finally, to test if there is a relationship between the Response and Predictors, we test the null
hypothesis
H0 : β1 = β2 = · · ·= βp = 0
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versus the alternative
Ha : at least one βj is not zero.
This hypothesis test is performed by computing the F statistic, F statistic
F = (TSS−RSS)/pRSS/(N −p−1) .
When there is no relationship between the response and the predictors, it can be shown that the F
statistic takes a value close to one. Conversely, if at least one βj is not zero, then it can be shown that
the F statistic takes a value greater than one.
How large does the F statistic need to be before we can reject H0 and conclude that there is a
relationship? It turns out that the answer depends on the values of N and p. For any given value of
N and p, any statistical software package can be used to compute the p-value associated with the F
statistic using this distribution. The p-value, given N and p, is the probability of observing the value p-value
of the F statistic assuming that β1 = · · ·= βp = 0.
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